context
stringlengths 21
24.6k
| category
stringclasses 2
values | entity
stringlengths 1
12
| entity_type
stringclasses 5
values | query
stringlengths 97
3.31k
| answer
stringlengths 12
168
|
|---|---|---|---|---|---|
Pursuant to a credit agreement (as amended to date, the “Credit Agreement”), the Company previously entered into a term loan totaling $ 1,500.0 million (as so amended and restated, the “Term Loan”), issued at a price equal to 99.75 % of its face value, and an accompanying $ 100.0 million revolving loan (the “Revolving Facility”). The maturity of the Term Loan is in September 2030. During the year ended December 31, 2024, the Company borrowed an additional $325.0 million under its Term Loan, comprised of $ 125.0 million on March 25, 2024 and $ 200.0 million on July 30, 2024. The additional amounts borrowed are fungible with the original $1,500.0 million and have the same maturity date, interest rate and other terms. The additional $125.0 million was issued at a price equal to 99.875 % of its face value, while the additional $200.0 million was issued at 99.0 % of its face value. | text | 200.0 | monetaryItemType | text: <entity> 200.0 </entity> <entity type> monetaryItemType </entity type> <context> Pursuant to a credit agreement (as amended to date, the “Credit Agreement”), the Company previously entered into a term loan totaling $ 1,500.0 million (as so amended and restated, the “Term Loan”), issued at a price equal to 99.75 % of its face value, and an accompanying $ 100.0 million revolving loan (the “Revolving Facility”). The maturity of the Term Loan is in September 2030. During the year ended December 31, 2024, the Company borrowed an additional $325.0 million under its Term Loan, comprised of $ 125.0 million on March 25, 2024 and $ 200.0 million on July 30, 2024. The additional amounts borrowed are fungible with the original $1,500.0 million and have the same maturity date, interest rate and other terms. The additional $125.0 million was issued at a price equal to 99.875 % of its face value, while the additional $200.0 million was issued at 99.0 % of its face value. </context> | us-gaap:ProceedsFromIssuanceOfDebt |
The Term Loan has been repriced on several occasions, most recently in June 2024, and currently bears interest at an annual rate equal to the Secured Overnight Financing Rate (“SOFR”) plus 2.25 %, with a 0.75 % SOFR floor. The Company typically selects a one-month interest period, with the result that interest is calculated using one-month SOFR. Interest is paid monthly on the last business day of the month. Principal payments, payable quarterly, equal $ 18.3 million per annum (one percent of the full principal amount of the Term Loan following the additional Term Loan amounts borrowed in 2024), with the remaining principal due upon maturity. | text | 2.25 | percentItemType | text: <entity> 2.25 </entity> <entity type> percentItemType </entity type> <context> The Term Loan has been repriced on several occasions, most recently in June 2024, and currently bears interest at an annual rate equal to the Secured Overnight Financing Rate (“SOFR”) plus 2.25 %, with a 0.75 % SOFR floor. The Company typically selects a one-month interest period, with the result that interest is calculated using one-month SOFR. Interest is paid monthly on the last business day of the month. Principal payments, payable quarterly, equal $ 18.3 million per annum (one percent of the full principal amount of the Term Loan following the additional Term Loan amounts borrowed in 2024), with the remaining principal due upon maturity. </context> | us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 |
The Term Loan has been repriced on several occasions, most recently in June 2024, and currently bears interest at an annual rate equal to the Secured Overnight Financing Rate (“SOFR”) plus 2.25 %, with a 0.75 % SOFR floor. The Company typically selects a one-month interest period, with the result that interest is calculated using one-month SOFR. Interest is paid monthly on the last business day of the month. Principal payments, payable quarterly, equal $ 18.3 million per annum (one percent of the full principal amount of the Term Loan following the additional Term Loan amounts borrowed in 2024), with the remaining principal due upon maturity. | text | 0.75 | percentItemType | text: <entity> 0.75 </entity> <entity type> percentItemType </entity type> <context> The Term Loan has been repriced on several occasions, most recently in June 2024, and currently bears interest at an annual rate equal to the Secured Overnight Financing Rate (“SOFR”) plus 2.25 %, with a 0.75 % SOFR floor. The Company typically selects a one-month interest period, with the result that interest is calculated using one-month SOFR. Interest is paid monthly on the last business day of the month. Principal payments, payable quarterly, equal $ 18.3 million per annum (one percent of the full principal amount of the Term Loan following the additional Term Loan amounts borrowed in 2024), with the remaining principal due upon maturity. </context> | us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 |
The Term Loan has been repriced on several occasions, most recently in June 2024, and currently bears interest at an annual rate equal to the Secured Overnight Financing Rate (“SOFR”) plus 2.25 %, with a 0.75 % SOFR floor. The Company typically selects a one-month interest period, with the result that interest is calculated using one-month SOFR. Interest is paid monthly on the last business day of the month. Principal payments, payable quarterly, equal $ 18.3 million per annum (one percent of the full principal amount of the Term Loan following the additional Term Loan amounts borrowed in 2024), with the remaining principal due upon maturity. | text | 18.3 | monetaryItemType | text: <entity> 18.3 </entity> <entity type> monetaryItemType </entity type> <context> The Term Loan has been repriced on several occasions, most recently in June 2024, and currently bears interest at an annual rate equal to the Secured Overnight Financing Rate (“SOFR”) plus 2.25 %, with a 0.75 % SOFR floor. The Company typically selects a one-month interest period, with the result that interest is calculated using one-month SOFR. Interest is paid monthly on the last business day of the month. Principal payments, payable quarterly, equal $ 18.3 million per annum (one percent of the full principal amount of the Term Loan following the additional Term Loan amounts borrowed in 2024), with the remaining principal due upon maturity. </context> | us-gaap:DebtInstrumentAnnualPrincipalPayment |
The Company paid fees of $ 2.3 million in connection with the expansion of the Term Loan in July 2024, $ 1.9 million related to the repricing of the Term Loan in June 2024 and $ 1.6 million in connection with the expansion of the Term Loan in March 2024, substantially all of which were expensed as incurred. The amounts expensed are included within interest expense. | text | 2.3 | monetaryItemType | text: <entity> 2.3 </entity> <entity type> monetaryItemType </entity type> <context> The Company paid fees of $ 2.3 million in connection with the expansion of the Term Loan in July 2024, $ 1.9 million related to the repricing of the Term Loan in June 2024 and $ 1.6 million in connection with the expansion of the Term Loan in March 2024, substantially all of which were expensed as incurred. The amounts expensed are included within interest expense. </context> | us-gaap:PaymentsOfFinancingCosts |
The Company paid fees of $ 2.3 million in connection with the expansion of the Term Loan in July 2024, $ 1.9 million related to the repricing of the Term Loan in June 2024 and $ 1.6 million in connection with the expansion of the Term Loan in March 2024, substantially all of which were expensed as incurred. The amounts expensed are included within interest expense. | text | 1.9 | monetaryItemType | text: <entity> 1.9 </entity> <entity type> monetaryItemType </entity type> <context> The Company paid fees of $ 2.3 million in connection with the expansion of the Term Loan in July 2024, $ 1.9 million related to the repricing of the Term Loan in June 2024 and $ 1.6 million in connection with the expansion of the Term Loan in March 2024, substantially all of which were expensed as incurred. The amounts expensed are included within interest expense. </context> | us-gaap:PaymentsOfFinancingCosts |
The Company paid fees of $ 2.3 million in connection with the expansion of the Term Loan in July 2024, $ 1.9 million related to the repricing of the Term Loan in June 2024 and $ 1.6 million in connection with the expansion of the Term Loan in March 2024, substantially all of which were expensed as incurred. The amounts expensed are included within interest expense. | text | 1.6 | monetaryItemType | text: <entity> 1.6 </entity> <entity type> monetaryItemType </entity type> <context> The Company paid fees of $ 2.3 million in connection with the expansion of the Term Loan in July 2024, $ 1.9 million related to the repricing of the Term Loan in June 2024 and $ 1.6 million in connection with the expansion of the Term Loan in March 2024, substantially all of which were expensed as incurred. The amounts expensed are included within interest expense. </context> | us-gaap:PaymentsOfFinancingCosts |
In September 2023, the Company paid $ 3.8 million of issuance costs to refinance the Term Loan, which costs were deferred and will be amortized through the term of the loan. Lenders making up approximately $ 16.8 million of the Term Loan did not participate in the refinancing. Those portions of the Term Loan were replaced by new or existing lenders. This resulted in an immaterial loss on extinguishment of debt, as the Company wrote off the unamortized debt issuance costs related to the lenders who were fully repaid in an exchange of principal. The Company deferred an additional $ 1.2 million of third-party fees associated with the refinancing of the Term Loan and the Revolving Facility in September 2023. | text | 3.8 | monetaryItemType | text: <entity> 3.8 </entity> <entity type> monetaryItemType </entity type> <context> In September 2023, the Company paid $ 3.8 million of issuance costs to refinance the Term Loan, which costs were deferred and will be amortized through the term of the loan. Lenders making up approximately $ 16.8 million of the Term Loan did not participate in the refinancing. Those portions of the Term Loan were replaced by new or existing lenders. This resulted in an immaterial loss on extinguishment of debt, as the Company wrote off the unamortized debt issuance costs related to the lenders who were fully repaid in an exchange of principal. The Company deferred an additional $ 1.2 million of third-party fees associated with the refinancing of the Term Loan and the Revolving Facility in September 2023. </context> | us-gaap:DeferredFinanceCostsGross |
In September 2023, the Company paid $ 3.8 million of issuance costs to refinance the Term Loan, which costs were deferred and will be amortized through the term of the loan. Lenders making up approximately $ 16.8 million of the Term Loan did not participate in the refinancing. Those portions of the Term Loan were replaced by new or existing lenders. This resulted in an immaterial loss on extinguishment of debt, as the Company wrote off the unamortized debt issuance costs related to the lenders who were fully repaid in an exchange of principal. The Company deferred an additional $ 1.2 million of third-party fees associated with the refinancing of the Term Loan and the Revolving Facility in September 2023. | text | 16.8 | monetaryItemType | text: <entity> 16.8 </entity> <entity type> monetaryItemType </entity type> <context> In September 2023, the Company paid $ 3.8 million of issuance costs to refinance the Term Loan, which costs were deferred and will be amortized through the term of the loan. Lenders making up approximately $ 16.8 million of the Term Loan did not participate in the refinancing. Those portions of the Term Loan were replaced by new or existing lenders. This resulted in an immaterial loss on extinguishment of debt, as the Company wrote off the unamortized debt issuance costs related to the lenders who were fully repaid in an exchange of principal. The Company deferred an additional $ 1.2 million of third-party fees associated with the refinancing of the Term Loan and the Revolving Facility in September 2023. </context> | us-gaap:ExtinguishmentOfDebtAmount |
In September 2023, the Company paid $ 3.8 million of issuance costs to refinance the Term Loan, which costs were deferred and will be amortized through the term of the loan. Lenders making up approximately $ 16.8 million of the Term Loan did not participate in the refinancing. Those portions of the Term Loan were replaced by new or existing lenders. This resulted in an immaterial loss on extinguishment of debt, as the Company wrote off the unamortized debt issuance costs related to the lenders who were fully repaid in an exchange of principal. The Company deferred an additional $ 1.2 million of third-party fees associated with the refinancing of the Term Loan and the Revolving Facility in September 2023. | text | 1.2 | monetaryItemType | text: <entity> 1.2 </entity> <entity type> monetaryItemType </entity type> <context> In September 2023, the Company paid $ 3.8 million of issuance costs to refinance the Term Loan, which costs were deferred and will be amortized through the term of the loan. Lenders making up approximately $ 16.8 million of the Term Loan did not participate in the refinancing. Those portions of the Term Loan were replaced by new or existing lenders. This resulted in an immaterial loss on extinguishment of debt, as the Company wrote off the unamortized debt issuance costs related to the lenders who were fully repaid in an exchange of principal. The Company deferred an additional $ 1.2 million of third-party fees associated with the refinancing of the Term Loan and the Revolving Facility in September 2023. </context> | us-gaap:DeferredFinanceCostsGross |
In the fourth quarter of 2022, the Company elected to prepay $ 100.0 million of principal on the Term Loan. This resulted in a $ 1.2 million loss on extinguishment of debt, as the Company wrote off the unamortized debt issuance costs related to this prepayment. | text | 100.0 | monetaryItemType | text: <entity> 100.0 </entity> <entity type> monetaryItemType </entity type> <context> In the fourth quarter of 2022, the Company elected to prepay $ 100.0 million of principal on the Term Loan. This resulted in a $ 1.2 million loss on extinguishment of debt, as the Company wrote off the unamortized debt issuance costs related to this prepayment. </context> | us-gaap:PaymentsOfDebtExtinguishmentCosts |
In the fourth quarter of 2022, the Company elected to prepay $ 100.0 million of principal on the Term Loan. This resulted in a $ 1.2 million loss on extinguishment of debt, as the Company wrote off the unamortized debt issuance costs related to this prepayment. | text | 1.2 | monetaryItemType | text: <entity> 1.2 </entity> <entity type> monetaryItemType </entity type> <context> In the fourth quarter of 2022, the Company elected to prepay $ 100.0 million of principal on the Term Loan. This resulted in a $ 1.2 million loss on extinguishment of debt, as the Company wrote off the unamortized debt issuance costs related to this prepayment. </context> | us-gaap:GainsLossesOnExtinguishmentOfDebt |
As of December 31, 2024 and 2023, the Company reported an aggregate of $ 1,807.7 million and $ 1,500.0 million in borrowings under the Term Loan, respectively. These amounts do not include $ 16.9 million and $ 17.5 million of net unamortized deferred financing costs as of December 31, 2024 and 2023, respectively. The net principal balance in borrowings in the accompanying consolidated balance sheets as of December 31, 2024 and 2023 amounted to $ 1,790.9 million and $ 1,482.5 million, respectively. As of December 31, 2024 and 2023, based upon over-the-counter bid levels (Level 2 - market approach), the fair value of the borrowings under the Term Loan was $ 1,802.1 million and | text | 1807.7 | monetaryItemType | text: <entity> 1807.7 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, the Company reported an aggregate of $ 1,807.7 million and $ 1,500.0 million in borrowings under the Term Loan, respectively. These amounts do not include $ 16.9 million and $ 17.5 million of net unamortized deferred financing costs as of December 31, 2024 and 2023, respectively. The net principal balance in borrowings in the accompanying consolidated balance sheets as of December 31, 2024 and 2023 amounted to $ 1,790.9 million and $ 1,482.5 million, respectively. As of December 31, 2024 and 2023, based upon over-the-counter bid levels (Level 2 - market approach), the fair value of the borrowings under the Term Loan was $ 1,802.1 million and </context> | us-gaap:DebtInstrumentCarryingAmount |
As of December 31, 2024 and 2023, the Company reported an aggregate of $ 1,807.7 million and $ 1,500.0 million in borrowings under the Term Loan, respectively. These amounts do not include $ 16.9 million and $ 17.5 million of net unamortized deferred financing costs as of December 31, 2024 and 2023, respectively. The net principal balance in borrowings in the accompanying consolidated balance sheets as of December 31, 2024 and 2023 amounted to $ 1,790.9 million and $ 1,482.5 million, respectively. As of December 31, 2024 and 2023, based upon over-the-counter bid levels (Level 2 - market approach), the fair value of the borrowings under the Term Loan was $ 1,802.1 million and | text | 1500.0 | monetaryItemType | text: <entity> 1500.0 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, the Company reported an aggregate of $ 1,807.7 million and $ 1,500.0 million in borrowings under the Term Loan, respectively. These amounts do not include $ 16.9 million and $ 17.5 million of net unamortized deferred financing costs as of December 31, 2024 and 2023, respectively. The net principal balance in borrowings in the accompanying consolidated balance sheets as of December 31, 2024 and 2023 amounted to $ 1,790.9 million and $ 1,482.5 million, respectively. As of December 31, 2024 and 2023, based upon over-the-counter bid levels (Level 2 - market approach), the fair value of the borrowings under the Term Loan was $ 1,802.1 million and </context> | us-gaap:DebtInstrumentCarryingAmount |
As of December 31, 2024 and 2023, the Company reported an aggregate of $ 1,807.7 million and $ 1,500.0 million in borrowings under the Term Loan, respectively. These amounts do not include $ 16.9 million and $ 17.5 million of net unamortized deferred financing costs as of December 31, 2024 and 2023, respectively. The net principal balance in borrowings in the accompanying consolidated balance sheets as of December 31, 2024 and 2023 amounted to $ 1,790.9 million and $ 1,482.5 million, respectively. As of December 31, 2024 and 2023, based upon over-the-counter bid levels (Level 2 - market approach), the fair value of the borrowings under the Term Loan was $ 1,802.1 million and | text | 16.9 | monetaryItemType | text: <entity> 16.9 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, the Company reported an aggregate of $ 1,807.7 million and $ 1,500.0 million in borrowings under the Term Loan, respectively. These amounts do not include $ 16.9 million and $ 17.5 million of net unamortized deferred financing costs as of December 31, 2024 and 2023, respectively. The net principal balance in borrowings in the accompanying consolidated balance sheets as of December 31, 2024 and 2023 amounted to $ 1,790.9 million and $ 1,482.5 million, respectively. As of December 31, 2024 and 2023, based upon over-the-counter bid levels (Level 2 - market approach), the fair value of the borrowings under the Term Loan was $ 1,802.1 million and </context> | us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet |
As of December 31, 2024 and 2023, the Company reported an aggregate of $ 1,807.7 million and $ 1,500.0 million in borrowings under the Term Loan, respectively. These amounts do not include $ 16.9 million and $ 17.5 million of net unamortized deferred financing costs as of December 31, 2024 and 2023, respectively. The net principal balance in borrowings in the accompanying consolidated balance sheets as of December 31, 2024 and 2023 amounted to $ 1,790.9 million and $ 1,482.5 million, respectively. As of December 31, 2024 and 2023, based upon over-the-counter bid levels (Level 2 - market approach), the fair value of the borrowings under the Term Loan was $ 1,802.1 million and | text | 17.5 | monetaryItemType | text: <entity> 17.5 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, the Company reported an aggregate of $ 1,807.7 million and $ 1,500.0 million in borrowings under the Term Loan, respectively. These amounts do not include $ 16.9 million and $ 17.5 million of net unamortized deferred financing costs as of December 31, 2024 and 2023, respectively. The net principal balance in borrowings in the accompanying consolidated balance sheets as of December 31, 2024 and 2023 amounted to $ 1,790.9 million and $ 1,482.5 million, respectively. As of December 31, 2024 and 2023, based upon over-the-counter bid levels (Level 2 - market approach), the fair value of the borrowings under the Term Loan was $ 1,802.1 million and </context> | us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet |
As of December 31, 2024 and 2023, the Company reported an aggregate of $ 1,807.7 million and $ 1,500.0 million in borrowings under the Term Loan, respectively. These amounts do not include $ 16.9 million and $ 17.5 million of net unamortized deferred financing costs as of December 31, 2024 and 2023, respectively. The net principal balance in borrowings in the accompanying consolidated balance sheets as of December 31, 2024 and 2023 amounted to $ 1,790.9 million and $ 1,482.5 million, respectively. As of December 31, 2024 and 2023, based upon over-the-counter bid levels (Level 2 - market approach), the fair value of the borrowings under the Term Loan was $ 1,802.1 million and | text | 1790.9 | monetaryItemType | text: <entity> 1790.9 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, the Company reported an aggregate of $ 1,807.7 million and $ 1,500.0 million in borrowings under the Term Loan, respectively. These amounts do not include $ 16.9 million and $ 17.5 million of net unamortized deferred financing costs as of December 31, 2024 and 2023, respectively. The net principal balance in borrowings in the accompanying consolidated balance sheets as of December 31, 2024 and 2023 amounted to $ 1,790.9 million and $ 1,482.5 million, respectively. As of December 31, 2024 and 2023, based upon over-the-counter bid levels (Level 2 - market approach), the fair value of the borrowings under the Term Loan was $ 1,802.1 million and </context> | us-gaap:LongTermDebt |
As of December 31, 2024 and 2023, the Company reported an aggregate of $ 1,807.7 million and $ 1,500.0 million in borrowings under the Term Loan, respectively. These amounts do not include $ 16.9 million and $ 17.5 million of net unamortized deferred financing costs as of December 31, 2024 and 2023, respectively. The net principal balance in borrowings in the accompanying consolidated balance sheets as of December 31, 2024 and 2023 amounted to $ 1,790.9 million and $ 1,482.5 million, respectively. As of December 31, 2024 and 2023, based upon over-the-counter bid levels (Level 2 - market approach), the fair value of the borrowings under the Term Loan was $ 1,802.1 million and | text | 1482.5 | monetaryItemType | text: <entity> 1482.5 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, the Company reported an aggregate of $ 1,807.7 million and $ 1,500.0 million in borrowings under the Term Loan, respectively. These amounts do not include $ 16.9 million and $ 17.5 million of net unamortized deferred financing costs as of December 31, 2024 and 2023, respectively. The net principal balance in borrowings in the accompanying consolidated balance sheets as of December 31, 2024 and 2023 amounted to $ 1,790.9 million and $ 1,482.5 million, respectively. As of December 31, 2024 and 2023, based upon over-the-counter bid levels (Level 2 - market approach), the fair value of the borrowings under the Term Loan was $ 1,802.1 million and </context> | us-gaap:LongTermDebt |
As of December 31, 2024 and 2023, the Company reported an aggregate of $ 1,807.7 million and $ 1,500.0 million in borrowings under the Term Loan, respectively. These amounts do not include $ 16.9 million and $ 17.5 million of net unamortized deferred financing costs as of December 31, 2024 and 2023, respectively. The net principal balance in borrowings in the accompanying consolidated balance sheets as of December 31, 2024 and 2023 amounted to $ 1,790.9 million and $ 1,482.5 million, respectively. As of December 31, 2024 and 2023, based upon over-the-counter bid levels (Level 2 - market approach), the fair value of the borrowings under the Term Loan was $ 1,802.1 million and | text | 1802.1 | monetaryItemType | text: <entity> 1802.1 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, the Company reported an aggregate of $ 1,807.7 million and $ 1,500.0 million in borrowings under the Term Loan, respectively. These amounts do not include $ 16.9 million and $ 17.5 million of net unamortized deferred financing costs as of December 31, 2024 and 2023, respectively. The net principal balance in borrowings in the accompanying consolidated balance sheets as of December 31, 2024 and 2023 amounted to $ 1,790.9 million and $ 1,482.5 million, respectively. As of December 31, 2024 and 2023, based upon over-the-counter bid levels (Level 2 - market approach), the fair value of the borrowings under the Term Loan was $ 1,802.1 million and </context> | us-gaap:LongTermDebtFairValue |
$ 1,506.6 million, respectively. The Company had no outstanding borrowings under the Revolving Facility as of December 31, 2024 or 2023. | text | 1506.6 | monetaryItemType | text: <entity> 1506.6 </entity> <entity type> monetaryItemType </entity type> <context> $ 1,506.6 million, respectively. The Company had no outstanding borrowings under the Revolving Facility as of December 31, 2024 or 2023. </context> | us-gaap:LongTermDebtFairValue |
Total interest incurred includes amortization of deferred financing fees and capitalized interest. The Company incurred third-party financing costs of $ 15.9 million in connection with the refinancing of the Term Loan in September 2023, of which $ 14.7 million was expensed. All third-party financing costs incurred during the years ended December 31, 2024 and 2023 were expensed. All amounts expensed are included within interest expense on the consolidated statements of operations and comprehensive income (loss). | text | 15.9 | monetaryItemType | text: <entity> 15.9 </entity> <entity type> monetaryItemType </entity type> <context> Total interest incurred includes amortization of deferred financing fees and capitalized interest. The Company incurred third-party financing costs of $ 15.9 million in connection with the refinancing of the Term Loan in September 2023, of which $ 14.7 million was expensed. All third-party financing costs incurred during the years ended December 31, 2024 and 2023 were expensed. All amounts expensed are included within interest expense on the consolidated statements of operations and comprehensive income (loss). </context> | us-gaap:PaymentsOfFinancingCosts |
Total interest incurred includes amortization of deferred financing fees and capitalized interest. The Company incurred third-party financing costs of $ 15.9 million in connection with the refinancing of the Term Loan in September 2023, of which $ 14.7 million was expensed. All third-party financing costs incurred during the years ended December 31, 2024 and 2023 were expensed. All amounts expensed are included within interest expense on the consolidated statements of operations and comprehensive income (loss). | text | 14.7 | monetaryItemType | text: <entity> 14.7 </entity> <entity type> monetaryItemType </entity type> <context> Total interest incurred includes amortization of deferred financing fees and capitalized interest. The Company incurred third-party financing costs of $ 15.9 million in connection with the refinancing of the Term Loan in September 2023, of which $ 14.7 million was expensed. All third-party financing costs incurred during the years ended December 31, 2024 and 2023 were expensed. All amounts expensed are included within interest expense on the consolidated statements of operations and comprehensive income (loss). </context> | us-gaap:InterestExpense |
As of December 31, 2024 and 2023, accrued interest under the Term Loan was $ 0.3 million and $ 1.0 million, respectively. | text | 0.3 | monetaryItemType | text: <entity> 0.3 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, accrued interest under the Term Loan was $ 0.3 million and $ 1.0 million, respectively. </context> | us-gaap:InterestPayableCurrentAndNoncurrent |
As of December 31, 2024 and 2023, accrued interest under the Term Loan was $ 0.3 million and $ 1.0 million, respectively. | text | 1.0 | monetaryItemType | text: <entity> 1.0 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, accrued interest under the Term Loan was $ 0.3 million and $ 1.0 million, respectively. </context> | us-gaap:InterestPayableCurrentAndNoncurrent |
In July 2021, the Company entered into the Cap, which had an effective date of December 2021. The Cap manages the Company’s exposure to interest rate movements on a portion of the Term Loan through November 2026. The Cap, as modified to date, currently provides the Company with the right to receive payment from the counterparty if one-month SOFR exceeds 1.436 %. The Company pays a fixed monthly premium based on an annual rate of 0.31 % for the Cap. The Cap carried a notional amount of $ 1.0 billion as of December 31, 2024 and 2023. | text | 1.436 | percentItemType | text: <entity> 1.436 </entity> <entity type> percentItemType </entity type> <context> In July 2021, the Company entered into the Cap, which had an effective date of December 2021. The Cap manages the Company’s exposure to interest rate movements on a portion of the Term Loan through November 2026. The Cap, as modified to date, currently provides the Company with the right to receive payment from the counterparty if one-month SOFR exceeds 1.436 %. The Company pays a fixed monthly premium based on an annual rate of 0.31 % for the Cap. The Cap carried a notional amount of $ 1.0 billion as of December 31, 2024 and 2023. </context> | us-gaap:DerivativeCapInterestRate |
In July 2021, the Company entered into the Cap, which had an effective date of December 2021. The Cap manages the Company’s exposure to interest rate movements on a portion of the Term Loan through November 2026. The Cap, as modified to date, currently provides the Company with the right to receive payment from the counterparty if one-month SOFR exceeds 1.436 %. The Company pays a fixed monthly premium based on an annual rate of 0.31 % for the Cap. The Cap carried a notional amount of $ 1.0 billion as of December 31, 2024 and 2023. | text | 0.31 | percentItemType | text: <entity> 0.31 </entity> <entity type> percentItemType </entity type> <context> In July 2021, the Company entered into the Cap, which had an effective date of December 2021. The Cap manages the Company’s exposure to interest rate movements on a portion of the Term Loan through November 2026. The Cap, as modified to date, currently provides the Company with the right to receive payment from the counterparty if one-month SOFR exceeds 1.436 %. The Company pays a fixed monthly premium based on an annual rate of 0.31 % for the Cap. The Cap carried a notional amount of $ 1.0 billion as of December 31, 2024 and 2023. </context> | us-gaap:DerivativeFixedInterestRate |
In July 2021, the Company entered into the Cap, which had an effective date of December 2021. The Cap manages the Company’s exposure to interest rate movements on a portion of the Term Loan through November 2026. The Cap, as modified to date, currently provides the Company with the right to receive payment from the counterparty if one-month SOFR exceeds 1.436 %. The Company pays a fixed monthly premium based on an annual rate of 0.31 % for the Cap. The Cap carried a notional amount of $ 1.0 billion as of December 31, 2024 and 2023. | text | 1.0 | monetaryItemType | text: <entity> 1.0 </entity> <entity type> monetaryItemType </entity type> <context> In July 2021, the Company entered into the Cap, which had an effective date of December 2021. The Cap manages the Company’s exposure to interest rate movements on a portion of the Term Loan through November 2026. The Cap, as modified to date, currently provides the Company with the right to receive payment from the counterparty if one-month SOFR exceeds 1.436 %. The Company pays a fixed monthly premium based on an annual rate of 0.31 % for the Cap. The Cap carried a notional amount of $ 1.0 billion as of December 31, 2024 and 2023. </context> | us-gaap:DerivativeNotionalAmount |
As of December 31, 2024 and 2023, the Company had an asset balance of $ 47.3 million and $ 66.5 million, respectively, for the fair value of the Cap, and a liability balance of $ 5.6 million and $ 8.4 million, respectively, for the fair value of the Cap premium. Both the Cap and the Cap premium are recorded within other assets on the consolidated balance sheet. | text | 47.3 | monetaryItemType | text: <entity> 47.3 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, the Company had an asset balance of $ 47.3 million and $ 66.5 million, respectively, for the fair value of the Cap, and a liability balance of $ 5.6 million and $ 8.4 million, respectively, for the fair value of the Cap premium. Both the Cap and the Cap premium are recorded within other assets on the consolidated balance sheet. </context> | us-gaap:InterestRateCashFlowHedgeAssetAtFairValue |
As of December 31, 2024 and 2023, the Company had an asset balance of $ 47.3 million and $ 66.5 million, respectively, for the fair value of the Cap, and a liability balance of $ 5.6 million and $ 8.4 million, respectively, for the fair value of the Cap premium. Both the Cap and the Cap premium are recorded within other assets on the consolidated balance sheet. | text | 66.5 | monetaryItemType | text: <entity> 66.5 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, the Company had an asset balance of $ 47.3 million and $ 66.5 million, respectively, for the fair value of the Cap, and a liability balance of $ 5.6 million and $ 8.4 million, respectively, for the fair value of the Cap premium. Both the Cap and the Cap premium are recorded within other assets on the consolidated balance sheet. </context> | us-gaap:InterestRateCashFlowHedgeAssetAtFairValue |
As of December 31, 2024 and 2023, the Company had an asset balance of $ 47.3 million and $ 66.5 million, respectively, for the fair value of the Cap, and a liability balance of $ 5.6 million and $ 8.4 million, respectively, for the fair value of the Cap premium. Both the Cap and the Cap premium are recorded within other assets on the consolidated balance sheet. | text | 5.6 | monetaryItemType | text: <entity> 5.6 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, the Company had an asset balance of $ 47.3 million and $ 66.5 million, respectively, for the fair value of the Cap, and a liability balance of $ 5.6 million and $ 8.4 million, respectively, for the fair value of the Cap premium. Both the Cap and the Cap premium are recorded within other assets on the consolidated balance sheet. </context> | us-gaap:InterestRateCashFlowHedgeLiabilityAtFairValue |
As of December 31, 2024 and 2023, the Company had an asset balance of $ 47.3 million and $ 66.5 million, respectively, for the fair value of the Cap, and a liability balance of $ 5.6 million and $ 8.4 million, respectively, for the fair value of the Cap premium. Both the Cap and the Cap premium are recorded within other assets on the consolidated balance sheet. | text | 8.4 | monetaryItemType | text: <entity> 8.4 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, the Company had an asset balance of $ 47.3 million and $ 66.5 million, respectively, for the fair value of the Cap, and a liability balance of $ 5.6 million and $ 8.4 million, respectively, for the fair value of the Cap premium. Both the Cap and the Cap premium are recorded within other assets on the consolidated balance sheet. </context> | us-gaap:InterestRateCashFlowHedgeLiabilityAtFairValue |
During each of the years ended December 31, 2024, 2023 and 2022 the Company collectively incurred $ 3.3 million in net interest expense for the cost of the interest rate hedges. Interest expense was reduced by $38.2 million, $ 36.2 million and $ 7.2 million for the years ended December 31, 2024, 2023 and 2022, respectively, for payments received related to the Cap. Gains and losses resulting from fair value adjustments to the Cap are recorded within accumulated other comprehensive income within the Company’s consolidated balance sheet and reclassified to interest expense on the dates that interest payments become due. Cash flows related to the derivative contracts are included in cash flows from operating activities on the consolidated statements of cash flows. Over the next 12 months, the Company expects any gains or losses for cash flow hedges amortized from accumulated other comprehensive income (loss) into earnings to have an immaterial impact on the Company’s consolidated financial statements. | text | 3.3 | monetaryItemType | text: <entity> 3.3 </entity> <entity type> monetaryItemType </entity type> <context> During each of the years ended December 31, 2024, 2023 and 2022 the Company collectively incurred $ 3.3 million in net interest expense for the cost of the interest rate hedges. Interest expense was reduced by $38.2 million, $ 36.2 million and $ 7.2 million for the years ended December 31, 2024, 2023 and 2022, respectively, for payments received related to the Cap. Gains and losses resulting from fair value adjustments to the Cap are recorded within accumulated other comprehensive income within the Company’s consolidated balance sheet and reclassified to interest expense on the dates that interest payments become due. Cash flows related to the derivative contracts are included in cash flows from operating activities on the consolidated statements of cash flows. Over the next 12 months, the Company expects any gains or losses for cash flow hedges amortized from accumulated other comprehensive income (loss) into earnings to have an immaterial impact on the Company’s consolidated financial statements. </context> | us-gaap:DerivativeGainLossOnDerivativeNet |
During each of the years ended December 31, 2024, 2023 and 2022 the Company collectively incurred $ 3.3 million in net interest expense for the cost of the interest rate hedges. Interest expense was reduced by $38.2 million, $ 36.2 million and $ 7.2 million for the years ended December 31, 2024, 2023 and 2022, respectively, for payments received related to the Cap. Gains and losses resulting from fair value adjustments to the Cap are recorded within accumulated other comprehensive income within the Company’s consolidated balance sheet and reclassified to interest expense on the dates that interest payments become due. Cash flows related to the derivative contracts are included in cash flows from operating activities on the consolidated statements of cash flows. Over the next 12 months, the Company expects any gains or losses for cash flow hedges amortized from accumulated other comprehensive income (loss) into earnings to have an immaterial impact on the Company’s consolidated financial statements. | text | 36.2 | monetaryItemType | text: <entity> 36.2 </entity> <entity type> monetaryItemType </entity type> <context> During each of the years ended December 31, 2024, 2023 and 2022 the Company collectively incurred $ 3.3 million in net interest expense for the cost of the interest rate hedges. Interest expense was reduced by $38.2 million, $ 36.2 million and $ 7.2 million for the years ended December 31, 2024, 2023 and 2022, respectively, for payments received related to the Cap. Gains and losses resulting from fair value adjustments to the Cap are recorded within accumulated other comprehensive income within the Company’s consolidated balance sheet and reclassified to interest expense on the dates that interest payments become due. Cash flows related to the derivative contracts are included in cash flows from operating activities on the consolidated statements of cash flows. Over the next 12 months, the Company expects any gains or losses for cash flow hedges amortized from accumulated other comprehensive income (loss) into earnings to have an immaterial impact on the Company’s consolidated financial statements. </context> | us-gaap:DerivativeGainOnDerivative |
During each of the years ended December 31, 2024, 2023 and 2022 the Company collectively incurred $ 3.3 million in net interest expense for the cost of the interest rate hedges. Interest expense was reduced by $38.2 million, $ 36.2 million and $ 7.2 million for the years ended December 31, 2024, 2023 and 2022, respectively, for payments received related to the Cap. Gains and losses resulting from fair value adjustments to the Cap are recorded within accumulated other comprehensive income within the Company’s consolidated balance sheet and reclassified to interest expense on the dates that interest payments become due. Cash flows related to the derivative contracts are included in cash flows from operating activities on the consolidated statements of cash flows. Over the next 12 months, the Company expects any gains or losses for cash flow hedges amortized from accumulated other comprehensive income (loss) into earnings to have an immaterial impact on the Company’s consolidated financial statements. | text | 7.2 | monetaryItemType | text: <entity> 7.2 </entity> <entity type> monetaryItemType </entity type> <context> During each of the years ended December 31, 2024, 2023 and 2022 the Company collectively incurred $ 3.3 million in net interest expense for the cost of the interest rate hedges. Interest expense was reduced by $38.2 million, $ 36.2 million and $ 7.2 million for the years ended December 31, 2024, 2023 and 2022, respectively, for payments received related to the Cap. Gains and losses resulting from fair value adjustments to the Cap are recorded within accumulated other comprehensive income within the Company’s consolidated balance sheet and reclassified to interest expense on the dates that interest payments become due. Cash flows related to the derivative contracts are included in cash flows from operating activities on the consolidated statements of cash flows. Over the next 12 months, the Company expects any gains or losses for cash flow hedges amortized from accumulated other comprehensive income (loss) into earnings to have an immaterial impact on the Company’s consolidated financial statements. </context> | us-gaap:DerivativeGainOnDerivative |
The Company is authorized to issue 2.0 million shares of preferred stock with a par value of $ 0.0001 per share. The Company previously issued 1.5 million shares of preferred stock. The remaining 0.5 million authorized shares of preferred stock remain undesignated and unissued as of December 31, 2024 and 2023. As of December 31, 2024 and 2023, there were no outstanding shares of preferred stock, as all previously designated and issued preferred stock was converted into common stock in prior periods. | text | 0.0001 | perShareItemType | text: <entity> 0.0001 </entity> <entity type> perShareItemType </entity type> <context> The Company is authorized to issue 2.0 million shares of preferred stock with a par value of $ 0.0001 per share. The Company previously issued 1.5 million shares of preferred stock. The remaining 0.5 million authorized shares of preferred stock remain undesignated and unissued as of December 31, 2024 and 2023. As of December 31, 2024 and 2023, there were no outstanding shares of preferred stock, as all previously designated and issued preferred stock was converted into common stock in prior periods. </context> | us-gaap:PreferredStockParOrStatedValuePerShare |
The Company is authorized to issue 2.0 million shares of preferred stock with a par value of $ 0.0001 per share. The Company previously issued 1.5 million shares of preferred stock. The remaining 0.5 million authorized shares of preferred stock remain undesignated and unissued as of December 31, 2024 and 2023. As of December 31, 2024 and 2023, there were no outstanding shares of preferred stock, as all previously designated and issued preferred stock was converted into common stock in prior periods. | text | 1.5 | sharesItemType | text: <entity> 1.5 </entity> <entity type> sharesItemType </entity type> <context> The Company is authorized to issue 2.0 million shares of preferred stock with a par value of $ 0.0001 per share. The Company previously issued 1.5 million shares of preferred stock. The remaining 0.5 million authorized shares of preferred stock remain undesignated and unissued as of December 31, 2024 and 2023. As of December 31, 2024 and 2023, there were no outstanding shares of preferred stock, as all previously designated and issued preferred stock was converted into common stock in prior periods. </context> | us-gaap:PreferredStockSharesIssued |
The Company is authorized to issue 2.0 million shares of preferred stock with a par value of $ 0.0001 per share. The Company previously issued 1.5 million shares of preferred stock. The remaining 0.5 million authorized shares of preferred stock remain undesignated and unissued as of December 31, 2024 and 2023. As of December 31, 2024 and 2023, there were no outstanding shares of preferred stock, as all previously designated and issued preferred stock was converted into common stock in prior periods. | text | 0.5 | sharesItemType | text: <entity> 0.5 </entity> <entity type> sharesItemType </entity type> <context> The Company is authorized to issue 2.0 million shares of preferred stock with a par value of $ 0.0001 per share. The Company previously issued 1.5 million shares of preferred stock. The remaining 0.5 million authorized shares of preferred stock remain undesignated and unissued as of December 31, 2024 and 2023. As of December 31, 2024 and 2023, there were no outstanding shares of preferred stock, as all previously designated and issued preferred stock was converted into common stock in prior periods. </context> | us-gaap:PreferredStockShareSubscriptions |
Stockholders are entitled to receive, when and if declared by the Company’s Board of Directors from time to time, such dividends and other distributions in cash, stock or property from the Company’s assets or funds legally and contractually available for such purposes. In December 2022, the Company’s Board of Directors initiated a quarterly dividend. The Company paid dividends of $ 0.13 per share of common stock for each quarter of 2023 and for the first quarter of 2024. The Company paid dividends of $ 0.14 per share of common stock for each of the quarters ended June 30, September 30 and December 31, 2024. The dividends resulted in total payments of $ 64.7 million and $ 64.8 million during the years ended 2024 and 2023, respectively. The Company’s liability related to dividends on common stock was $ 2.5 million and $ 1.3 million as of December 31, 2024 and 2023, respectively. | text | 0.13 | perShareItemType | text: <entity> 0.13 </entity> <entity type> perShareItemType </entity type> <context> Stockholders are entitled to receive, when and if declared by the Company’s Board of Directors from time to time, such dividends and other distributions in cash, stock or property from the Company’s assets or funds legally and contractually available for such purposes. In December 2022, the Company’s Board of Directors initiated a quarterly dividend. The Company paid dividends of $ 0.13 per share of common stock for each quarter of 2023 and for the first quarter of 2024. The Company paid dividends of $ 0.14 per share of common stock for each of the quarters ended June 30, September 30 and December 31, 2024. The dividends resulted in total payments of $ 64.7 million and $ 64.8 million during the years ended 2024 and 2023, respectively. The Company’s liability related to dividends on common stock was $ 2.5 million and $ 1.3 million as of December 31, 2024 and 2023, respectively. </context> | us-gaap:CommonStockDividendsPerShareDeclared |
Stockholders are entitled to receive, when and if declared by the Company’s Board of Directors from time to time, such dividends and other distributions in cash, stock or property from the Company’s assets or funds legally and contractually available for such purposes. In December 2022, the Company’s Board of Directors initiated a quarterly dividend. The Company paid dividends of $ 0.13 per share of common stock for each quarter of 2023 and for the first quarter of 2024. The Company paid dividends of $ 0.14 per share of common stock for each of the quarters ended June 30, September 30 and December 31, 2024. The dividends resulted in total payments of $ 64.7 million and $ 64.8 million during the years ended 2024 and 2023, respectively. The Company’s liability related to dividends on common stock was $ 2.5 million and $ 1.3 million as of December 31, 2024 and 2023, respectively. | text | 64.7 | monetaryItemType | text: <entity> 64.7 </entity> <entity type> monetaryItemType </entity type> <context> Stockholders are entitled to receive, when and if declared by the Company’s Board of Directors from time to time, such dividends and other distributions in cash, stock or property from the Company’s assets or funds legally and contractually available for such purposes. In December 2022, the Company’s Board of Directors initiated a quarterly dividend. The Company paid dividends of $ 0.13 per share of common stock for each quarter of 2023 and for the first quarter of 2024. The Company paid dividends of $ 0.14 per share of common stock for each of the quarters ended June 30, September 30 and December 31, 2024. The dividends resulted in total payments of $ 64.7 million and $ 64.8 million during the years ended 2024 and 2023, respectively. The Company’s liability related to dividends on common stock was $ 2.5 million and $ 1.3 million as of December 31, 2024 and 2023, respectively. </context> | us-gaap:PaymentsOfDividendsCommonStock |
Stockholders are entitled to receive, when and if declared by the Company’s Board of Directors from time to time, such dividends and other distributions in cash, stock or property from the Company’s assets or funds legally and contractually available for such purposes. In December 2022, the Company’s Board of Directors initiated a quarterly dividend. The Company paid dividends of $ 0.13 per share of common stock for each quarter of 2023 and for the first quarter of 2024. The Company paid dividends of $ 0.14 per share of common stock for each of the quarters ended June 30, September 30 and December 31, 2024. The dividends resulted in total payments of $ 64.7 million and $ 64.8 million during the years ended 2024 and 2023, respectively. The Company’s liability related to dividends on common stock was $ 2.5 million and $ 1.3 million as of December 31, 2024 and 2023, respectively. | text | 64.8 | monetaryItemType | text: <entity> 64.8 </entity> <entity type> monetaryItemType </entity type> <context> Stockholders are entitled to receive, when and if declared by the Company’s Board of Directors from time to time, such dividends and other distributions in cash, stock or property from the Company’s assets or funds legally and contractually available for such purposes. In December 2022, the Company’s Board of Directors initiated a quarterly dividend. The Company paid dividends of $ 0.13 per share of common stock for each quarter of 2023 and for the first quarter of 2024. The Company paid dividends of $ 0.14 per share of common stock for each of the quarters ended June 30, September 30 and December 31, 2024. The dividends resulted in total payments of $ 64.7 million and $ 64.8 million during the years ended 2024 and 2023, respectively. The Company’s liability related to dividends on common stock was $ 2.5 million and $ 1.3 million as of December 31, 2024 and 2023, respectively. </context> | us-gaap:PaymentsOfDividendsCommonStock |
Stockholders are entitled to receive, when and if declared by the Company’s Board of Directors from time to time, such dividends and other distributions in cash, stock or property from the Company’s assets or funds legally and contractually available for such purposes. In December 2022, the Company’s Board of Directors initiated a quarterly dividend. The Company paid dividends of $ 0.13 per share of common stock for each quarter of 2023 and for the first quarter of 2024. The Company paid dividends of $ 0.14 per share of common stock for each of the quarters ended June 30, September 30 and December 31, 2024. The dividends resulted in total payments of $ 64.7 million and $ 64.8 million during the years ended 2024 and 2023, respectively. The Company’s liability related to dividends on common stock was $ 2.5 million and $ 1.3 million as of December 31, 2024 and 2023, respectively. | text | 2.5 | monetaryItemType | text: <entity> 2.5 </entity> <entity type> monetaryItemType </entity type> <context> Stockholders are entitled to receive, when and if declared by the Company’s Board of Directors from time to time, such dividends and other distributions in cash, stock or property from the Company’s assets or funds legally and contractually available for such purposes. In December 2022, the Company’s Board of Directors initiated a quarterly dividend. The Company paid dividends of $ 0.13 per share of common stock for each quarter of 2023 and for the first quarter of 2024. The Company paid dividends of $ 0.14 per share of common stock for each of the quarters ended June 30, September 30 and December 31, 2024. The dividends resulted in total payments of $ 64.7 million and $ 64.8 million during the years ended 2024 and 2023, respectively. The Company’s liability related to dividends on common stock was $ 2.5 million and $ 1.3 million as of December 31, 2024 and 2023, respectively. </context> | us-gaap:DividendsPayableCurrentAndNoncurrent |
Stockholders are entitled to receive, when and if declared by the Company’s Board of Directors from time to time, such dividends and other distributions in cash, stock or property from the Company’s assets or funds legally and contractually available for such purposes. In December 2022, the Company’s Board of Directors initiated a quarterly dividend. The Company paid dividends of $ 0.13 per share of common stock for each quarter of 2023 and for the first quarter of 2024. The Company paid dividends of $ 0.14 per share of common stock for each of the quarters ended June 30, September 30 and December 31, 2024. The dividends resulted in total payments of $ 64.7 million and $ 64.8 million during the years ended 2024 and 2023, respectively. The Company’s liability related to dividends on common stock was $ 2.5 million and $ 1.3 million as of December 31, 2024 and 2023, respectively. | text | 1.3 | monetaryItemType | text: <entity> 1.3 </entity> <entity type> monetaryItemType </entity type> <context> Stockholders are entitled to receive, when and if declared by the Company’s Board of Directors from time to time, such dividends and other distributions in cash, stock or property from the Company’s assets or funds legally and contractually available for such purposes. In December 2022, the Company’s Board of Directors initiated a quarterly dividend. The Company paid dividends of $ 0.13 per share of common stock for each quarter of 2023 and for the first quarter of 2024. The Company paid dividends of $ 0.14 per share of common stock for each of the quarters ended June 30, September 30 and December 31, 2024. The dividends resulted in total payments of $ 64.7 million and $ 64.8 million during the years ended 2024 and 2023, respectively. The Company’s liability related to dividends on common stock was $ 2.5 million and $ 1.3 million as of December 31, 2024 and 2023, respectively. </context> | us-gaap:DividendsPayableCurrentAndNoncurrent |
The Company repurchased and subsequently retired 14.0 million, 4.8 million and 6.8 million shares of its common stock during the years ended December 31, 2024, 2023 and 2022, respectively, for a total purchase price of $ 403.8 million, $ 244.6 million and $ 257.0 million, respectively, exclusive of $ 3.6 million and $1.4 million of excise taxes incurred in the year ended December 31, 2024 and 2023, respectively, with no such taxes incurred in the year ended December 31, 2022. In addition, in | text | 14.0 | sharesItemType | text: <entity> 14.0 </entity> <entity type> sharesItemType </entity type> <context> The Company repurchased and subsequently retired 14.0 million, 4.8 million and 6.8 million shares of its common stock during the years ended December 31, 2024, 2023 and 2022, respectively, for a total purchase price of $ 403.8 million, $ 244.6 million and $ 257.0 million, respectively, exclusive of $ 3.6 million and $1.4 million of excise taxes incurred in the year ended December 31, 2024 and 2023, respectively, with no such taxes incurred in the year ended December 31, 2022. In addition, in </context> | us-gaap:TreasuryStockSharesRetired |
The Company repurchased and subsequently retired 14.0 million, 4.8 million and 6.8 million shares of its common stock during the years ended December 31, 2024, 2023 and 2022, respectively, for a total purchase price of $ 403.8 million, $ 244.6 million and $ 257.0 million, respectively, exclusive of $ 3.6 million and $1.4 million of excise taxes incurred in the year ended December 31, 2024 and 2023, respectively, with no such taxes incurred in the year ended December 31, 2022. In addition, in | text | 4.8 | sharesItemType | text: <entity> 4.8 </entity> <entity type> sharesItemType </entity type> <context> The Company repurchased and subsequently retired 14.0 million, 4.8 million and 6.8 million shares of its common stock during the years ended December 31, 2024, 2023 and 2022, respectively, for a total purchase price of $ 403.8 million, $ 244.6 million and $ 257.0 million, respectively, exclusive of $ 3.6 million and $1.4 million of excise taxes incurred in the year ended December 31, 2024 and 2023, respectively, with no such taxes incurred in the year ended December 31, 2022. In addition, in </context> | us-gaap:TreasuryStockSharesRetired |
The Company repurchased and subsequently retired 14.0 million, 4.8 million and 6.8 million shares of its common stock during the years ended December 31, 2024, 2023 and 2022, respectively, for a total purchase price of $ 403.8 million, $ 244.6 million and $ 257.0 million, respectively, exclusive of $ 3.6 million and $1.4 million of excise taxes incurred in the year ended December 31, 2024 and 2023, respectively, with no such taxes incurred in the year ended December 31, 2022. In addition, in | text | 6.8 | sharesItemType | text: <entity> 6.8 </entity> <entity type> sharesItemType </entity type> <context> The Company repurchased and subsequently retired 14.0 million, 4.8 million and 6.8 million shares of its common stock during the years ended December 31, 2024, 2023 and 2022, respectively, for a total purchase price of $ 403.8 million, $ 244.6 million and $ 257.0 million, respectively, exclusive of $ 3.6 million and $1.4 million of excise taxes incurred in the year ended December 31, 2024 and 2023, respectively, with no such taxes incurred in the year ended December 31, 2022. In addition, in </context> | us-gaap:TreasuryStockSharesRetired |
The Company repurchased and subsequently retired 14.0 million, 4.8 million and 6.8 million shares of its common stock during the years ended December 31, 2024, 2023 and 2022, respectively, for a total purchase price of $ 403.8 million, $ 244.6 million and $ 257.0 million, respectively, exclusive of $ 3.6 million and $1.4 million of excise taxes incurred in the year ended December 31, 2024 and 2023, respectively, with no such taxes incurred in the year ended December 31, 2022. In addition, in | text | 403.8 | monetaryItemType | text: <entity> 403.8 </entity> <entity type> monetaryItemType </entity type> <context> The Company repurchased and subsequently retired 14.0 million, 4.8 million and 6.8 million shares of its common stock during the years ended December 31, 2024, 2023 and 2022, respectively, for a total purchase price of $ 403.8 million, $ 244.6 million and $ 257.0 million, respectively, exclusive of $ 3.6 million and $1.4 million of excise taxes incurred in the year ended December 31, 2024 and 2023, respectively, with no such taxes incurred in the year ended December 31, 2022. In addition, in </context> | us-gaap:TreasuryStockRetiredCostMethodAmount |
The Company repurchased and subsequently retired 14.0 million, 4.8 million and 6.8 million shares of its common stock during the years ended December 31, 2024, 2023 and 2022, respectively, for a total purchase price of $ 403.8 million, $ 244.6 million and $ 257.0 million, respectively, exclusive of $ 3.6 million and $1.4 million of excise taxes incurred in the year ended December 31, 2024 and 2023, respectively, with no such taxes incurred in the year ended December 31, 2022. In addition, in | text | 244.6 | monetaryItemType | text: <entity> 244.6 </entity> <entity type> monetaryItemType </entity type> <context> The Company repurchased and subsequently retired 14.0 million, 4.8 million and 6.8 million shares of its common stock during the years ended December 31, 2024, 2023 and 2022, respectively, for a total purchase price of $ 403.8 million, $ 244.6 million and $ 257.0 million, respectively, exclusive of $ 3.6 million and $1.4 million of excise taxes incurred in the year ended December 31, 2024 and 2023, respectively, with no such taxes incurred in the year ended December 31, 2022. In addition, in </context> | us-gaap:TreasuryStockRetiredCostMethodAmount |
The Company repurchased and subsequently retired 14.0 million, 4.8 million and 6.8 million shares of its common stock during the years ended December 31, 2024, 2023 and 2022, respectively, for a total purchase price of $ 403.8 million, $ 244.6 million and $ 257.0 million, respectively, exclusive of $ 3.6 million and $1.4 million of excise taxes incurred in the year ended December 31, 2024 and 2023, respectively, with no such taxes incurred in the year ended December 31, 2022. In addition, in | text | 257.0 | monetaryItemType | text: <entity> 257.0 </entity> <entity type> monetaryItemType </entity type> <context> The Company repurchased and subsequently retired 14.0 million, 4.8 million and 6.8 million shares of its common stock during the years ended December 31, 2024, 2023 and 2022, respectively, for a total purchase price of $ 403.8 million, $ 244.6 million and $ 257.0 million, respectively, exclusive of $ 3.6 million and $1.4 million of excise taxes incurred in the year ended December 31, 2024 and 2023, respectively, with no such taxes incurred in the year ended December 31, 2022. In addition, in </context> | us-gaap:TreasuryStockRetiredCostMethodAmount |
The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and deferred revenue (contract liabilities) on the consolidated balance sheets. The Company bills amounts under its agreed-upon contractual terms at periodic intervals (for services), upon shipment (for equipment), or upon achievement of contractual milestones or as work progresses (for engineering and support services). Billing may occur subsequent to revenue recognition, resulting in unbilled accounts receivable (contract assets). The Company may also receive payments from customers before revenue is recognized, resulting in deferred revenue (contract liabilities). The Company recognized revenue that was previously recorded as deferred revenue in the amounts of $ 36.9 million, $ 31.4 million and $ 26.3 million for the years ended December 31, 2024, 2023 and 2022, respectively. | text | 36.9 | monetaryItemType | text: <entity> 36.9 </entity> <entity type> monetaryItemType </entity type> <context> The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and deferred revenue (contract liabilities) on the consolidated balance sheets. The Company bills amounts under its agreed-upon contractual terms at periodic intervals (for services), upon shipment (for equipment), or upon achievement of contractual milestones or as work progresses (for engineering and support services). Billing may occur subsequent to revenue recognition, resulting in unbilled accounts receivable (contract assets). The Company may also receive payments from customers before revenue is recognized, resulting in deferred revenue (contract liabilities). The Company recognized revenue that was previously recorded as deferred revenue in the amounts of $ 36.9 million, $ 31.4 million and $ 26.3 million for the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:ContractWithCustomerLiabilityRevenueRecognized |
The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and deferred revenue (contract liabilities) on the consolidated balance sheets. The Company bills amounts under its agreed-upon contractual terms at periodic intervals (for services), upon shipment (for equipment), or upon achievement of contractual milestones or as work progresses (for engineering and support services). Billing may occur subsequent to revenue recognition, resulting in unbilled accounts receivable (contract assets). The Company may also receive payments from customers before revenue is recognized, resulting in deferred revenue (contract liabilities). The Company recognized revenue that was previously recorded as deferred revenue in the amounts of $ 36.9 million, $ 31.4 million and $ 26.3 million for the years ended December 31, 2024, 2023 and 2022, respectively. | text | 31.4 | monetaryItemType | text: <entity> 31.4 </entity> <entity type> monetaryItemType </entity type> <context> The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and deferred revenue (contract liabilities) on the consolidated balance sheets. The Company bills amounts under its agreed-upon contractual terms at periodic intervals (for services), upon shipment (for equipment), or upon achievement of contractual milestones or as work progresses (for engineering and support services). Billing may occur subsequent to revenue recognition, resulting in unbilled accounts receivable (contract assets). The Company may also receive payments from customers before revenue is recognized, resulting in deferred revenue (contract liabilities). The Company recognized revenue that was previously recorded as deferred revenue in the amounts of $ 36.9 million, $ 31.4 million and $ 26.3 million for the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:ContractWithCustomerLiabilityRevenueRecognized |
The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and deferred revenue (contract liabilities) on the consolidated balance sheets. The Company bills amounts under its agreed-upon contractual terms at periodic intervals (for services), upon shipment (for equipment), or upon achievement of contractual milestones or as work progresses (for engineering and support services). Billing may occur subsequent to revenue recognition, resulting in unbilled accounts receivable (contract assets). The Company may also receive payments from customers before revenue is recognized, resulting in deferred revenue (contract liabilities). The Company recognized revenue that was previously recorded as deferred revenue in the amounts of $ 36.9 million, $ 31.4 million and $ 26.3 million for the years ended December 31, 2024, 2023 and 2022, respectively. | text | 26.3 | monetaryItemType | text: <entity> 26.3 </entity> <entity type> monetaryItemType </entity type> <context> The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and deferred revenue (contract liabilities) on the consolidated balance sheets. The Company bills amounts under its agreed-upon contractual terms at periodic intervals (for services), upon shipment (for equipment), or upon achievement of contractual milestones or as work progresses (for engineering and support services). Billing may occur subsequent to revenue recognition, resulting in unbilled accounts receivable (contract assets). The Company may also receive payments from customers before revenue is recognized, resulting in deferred revenue (contract liabilities). The Company recognized revenue that was previously recorded as deferred revenue in the amounts of $ 36.9 million, $ 31.4 million and $ 26.3 million for the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:ContractWithCustomerLiabilityRevenueRecognized |
The Company has operating leases for land, office space, satellite network operations center (“SNOC”) facilities, system gateway facilities, a warehouse and a distribution center. The Company also has operations and maintenance (“O&M”) agreements that include leases associated with two teleport network facilities. Some of the Company’s leases include options to extend the leases for up to 8 years. The Company does not include term extension options as part of its present value calculation of lease liabilities unless it is reasonably certain to exercise those options. As of December 31, 2024, the Company’s weighted-average remaining lease term relating to its operating leases was 4.4 years, and the weighted-average discount rate used to calculate the operating lease liability payment was 6.8 %. | text | 6.8 | percentItemType | text: <entity> 6.8 </entity> <entity type> percentItemType </entity type> <context> The Company has operating leases for land, office space, satellite network operations center (“SNOC”) facilities, system gateway facilities, a warehouse and a distribution center. The Company also has operations and maintenance (“O&M”) agreements that include leases associated with two teleport network facilities. Some of the Company’s leases include options to extend the leases for up to 8 years. The Company does not include term extension options as part of its present value calculation of lease liabilities unless it is reasonably certain to exercise those options. As of December 31, 2024, the Company’s weighted-average remaining lease term relating to its operating leases was 4.4 years, and the weighted-average discount rate used to calculate the operating lease liability payment was 6.8 %. </context> | us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent |
During the years ended December 31, 2024, 2023 and 2022, the Company incurred lease expense of $ 6.0 million, $ 5.2 million and $ 5.2 million, respectively. A portion of lease expense during these comparable periods was derived from leases that were not included within the ROU asset and liability balances shown above as they had terms shorter than twelve months and were therefore excluded from balance sheet recognition under ASU 2016-02. | text | 6.0 | monetaryItemType | text: <entity> 6.0 </entity> <entity type> monetaryItemType </entity type> <context> During the years ended December 31, 2024, 2023 and 2022, the Company incurred lease expense of $ 6.0 million, $ 5.2 million and $ 5.2 million, respectively. A portion of lease expense during these comparable periods was derived from leases that were not included within the ROU asset and liability balances shown above as they had terms shorter than twelve months and were therefore excluded from balance sheet recognition under ASU 2016-02. </context> | us-gaap:OperatingLeaseExpense |
During the years ended December 31, 2024, 2023 and 2022, the Company incurred lease expense of $ 6.0 million, $ 5.2 million and $ 5.2 million, respectively. A portion of lease expense during these comparable periods was derived from leases that were not included within the ROU asset and liability balances shown above as they had terms shorter than twelve months and were therefore excluded from balance sheet recognition under ASU 2016-02. | text | 5.2 | monetaryItemType | text: <entity> 5.2 </entity> <entity type> monetaryItemType </entity type> <context> During the years ended December 31, 2024, 2023 and 2022, the Company incurred lease expense of $ 6.0 million, $ 5.2 million and $ 5.2 million, respectively. A portion of lease expense during these comparable periods was derived from leases that were not included within the ROU asset and liability balances shown above as they had terms shorter than twelve months and were therefore excluded from balance sheet recognition under ASU 2016-02. </context> | us-gaap:OperatingLeaseExpense |
and L3Harris Technologies, Inc. (“L3Harris”) for space on the Company’s satellites. These agreements provide for a fee that will be recognized over the estimated useful lives of the satellites, which is now approximately 17.5 years, prospectively from the change in estimated useful lives of the satellites that occurred in the fourth quarter of 2023. Lease income related to these agreements for the years ended December 31, 2024, 2023 and 2022 was $ 12.4 million, $ 19.2 million and $ 21.4 million, respectively. The decreases in 2024 and 2023 as compared to 2022 were solely the result of the timing of the change in estimated useful life of the satellites. Lease income is recorded as hosted payload and other data service revenue within service revenue on the Company’s consolidated statements of operations and comprehensive income (loss). | text | 12.4 | monetaryItemType | text: <entity> 12.4 </entity> <entity type> monetaryItemType </entity type> <context> and L3Harris Technologies, Inc. (“L3Harris”) for space on the Company’s satellites. These agreements provide for a fee that will be recognized over the estimated useful lives of the satellites, which is now approximately 17.5 years, prospectively from the change in estimated useful lives of the satellites that occurred in the fourth quarter of 2023. Lease income related to these agreements for the years ended December 31, 2024, 2023 and 2022 was $ 12.4 million, $ 19.2 million and $ 21.4 million, respectively. The decreases in 2024 and 2023 as compared to 2022 were solely the result of the timing of the change in estimated useful life of the satellites. Lease income is recorded as hosted payload and other data service revenue within service revenue on the Company’s consolidated statements of operations and comprehensive income (loss). </context> | us-gaap:OperatingLeaseLeaseIncome |
and L3Harris Technologies, Inc. (“L3Harris”) for space on the Company’s satellites. These agreements provide for a fee that will be recognized over the estimated useful lives of the satellites, which is now approximately 17.5 years, prospectively from the change in estimated useful lives of the satellites that occurred in the fourth quarter of 2023. Lease income related to these agreements for the years ended December 31, 2024, 2023 and 2022 was $ 12.4 million, $ 19.2 million and $ 21.4 million, respectively. The decreases in 2024 and 2023 as compared to 2022 were solely the result of the timing of the change in estimated useful life of the satellites. Lease income is recorded as hosted payload and other data service revenue within service revenue on the Company’s consolidated statements of operations and comprehensive income (loss). | text | 19.2 | monetaryItemType | text: <entity> 19.2 </entity> <entity type> monetaryItemType </entity type> <context> and L3Harris Technologies, Inc. (“L3Harris”) for space on the Company’s satellites. These agreements provide for a fee that will be recognized over the estimated useful lives of the satellites, which is now approximately 17.5 years, prospectively from the change in estimated useful lives of the satellites that occurred in the fourth quarter of 2023. Lease income related to these agreements for the years ended December 31, 2024, 2023 and 2022 was $ 12.4 million, $ 19.2 million and $ 21.4 million, respectively. The decreases in 2024 and 2023 as compared to 2022 were solely the result of the timing of the change in estimated useful life of the satellites. Lease income is recorded as hosted payload and other data service revenue within service revenue on the Company’s consolidated statements of operations and comprehensive income (loss). </context> | us-gaap:OperatingLeaseLeaseIncome |
and L3Harris Technologies, Inc. (“L3Harris”) for space on the Company’s satellites. These agreements provide for a fee that will be recognized over the estimated useful lives of the satellites, which is now approximately 17.5 years, prospectively from the change in estimated useful lives of the satellites that occurred in the fourth quarter of 2023. Lease income related to these agreements for the years ended December 31, 2024, 2023 and 2022 was $ 12.4 million, $ 19.2 million and $ 21.4 million, respectively. The decreases in 2024 and 2023 as compared to 2022 were solely the result of the timing of the change in estimated useful life of the satellites. Lease income is recorded as hosted payload and other data service revenue within service revenue on the Company’s consolidated statements of operations and comprehensive income (loss). | text | 21.4 | monetaryItemType | text: <entity> 21.4 </entity> <entity type> monetaryItemType </entity type> <context> and L3Harris Technologies, Inc. (“L3Harris”) for space on the Company’s satellites. These agreements provide for a fee that will be recognized over the estimated useful lives of the satellites, which is now approximately 17.5 years, prospectively from the change in estimated useful lives of the satellites that occurred in the fourth quarter of 2023. Lease income related to these agreements for the years ended December 31, 2024, 2023 and 2022 was $ 12.4 million, $ 19.2 million and $ 21.4 million, respectively. The decreases in 2024 and 2023 as compared to 2022 were solely the result of the timing of the change in estimated useful life of the satellites. Lease income is recorded as hosted payload and other data service revenue within service revenue on the Company’s consolidated statements of operations and comprehensive income (loss). </context> | us-gaap:OperatingLeaseLeaseIncome |
In May 2023, the Company’s stockholders approved the amendment and restatement of the Company’s 2015 Equity Incentive Plan (as so amended and restated, the “Amended 2015 Plan”). As of December 31, 2024, the remaining aggregate number of shares of the Company’s common stock available for future grants under the Amended 2015 Plan was 8,410,558 . The Amended 2015 Plan provides for the grant of stock-based awards, including nonqualified stock options, incentive stock options, restricted stock, restricted stock units (“RSUs”), stock appreciation rights and other equity securities to employees, consultants and non-employee directors of the Company and its affiliated entities. The number of shares of common stock available for issuance under the Amended 2015 Plan is reduced by (i) one share for each share of common stock issued pursuant to an appreciation award, such as a stock option or stock appreciation right with an exercise or strike price of at least 100 % of the fair market value of the underlying common stock on the date of grant, and (ii) 1.8 shares for each share of common stock issued pursuant to any stock award that is not an appreciation award, also referred to as a “full value award.” The Amended 2015 Plan allows the Company to utilize a broad array of equity incentives and performance cash incentives in order to secure and retain the services of its employees, directors and consultants, and to provide long-term incentives that align the interests of its employees, directors and consultants with the interests of the Company’s stockholders. The Company accounts for stock-based compensation at estimated fair value. | text | 8410558 | sharesItemType | text: <entity> 8410558 </entity> <entity type> sharesItemType </entity type> <context> In May 2023, the Company’s stockholders approved the amendment and restatement of the Company’s 2015 Equity Incentive Plan (as so amended and restated, the “Amended 2015 Plan”). As of December 31, 2024, the remaining aggregate number of shares of the Company’s common stock available for future grants under the Amended 2015 Plan was 8,410,558 . The Amended 2015 Plan provides for the grant of stock-based awards, including nonqualified stock options, incentive stock options, restricted stock, restricted stock units (“RSUs”), stock appreciation rights and other equity securities to employees, consultants and non-employee directors of the Company and its affiliated entities. The number of shares of common stock available for issuance under the Amended 2015 Plan is reduced by (i) one share for each share of common stock issued pursuant to an appreciation award, such as a stock option or stock appreciation right with an exercise or strike price of at least 100 % of the fair market value of the underlying common stock on the date of grant, and (ii) 1.8 shares for each share of common stock issued pursuant to any stock award that is not an appreciation award, also referred to as a “full value award.” The Amended 2015 Plan allows the Company to utilize a broad array of equity incentives and performance cash incentives in order to secure and retain the services of its employees, directors and consultants, and to provide long-term incentives that align the interests of its employees, directors and consultants with the interests of the Company’s stockholders. The Company accounts for stock-based compensation at estimated fair value. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant |
In May 2023, the Company’s stockholders approved the amendment and restatement of the Company’s 2015 Equity Incentive Plan (as so amended and restated, the “Amended 2015 Plan”). As of December 31, 2024, the remaining aggregate number of shares of the Company’s common stock available for future grants under the Amended 2015 Plan was 8,410,558 . The Amended 2015 Plan provides for the grant of stock-based awards, including nonqualified stock options, incentive stock options, restricted stock, restricted stock units (“RSUs”), stock appreciation rights and other equity securities to employees, consultants and non-employee directors of the Company and its affiliated entities. The number of shares of common stock available for issuance under the Amended 2015 Plan is reduced by (i) one share for each share of common stock issued pursuant to an appreciation award, such as a stock option or stock appreciation right with an exercise or strike price of at least 100 % of the fair market value of the underlying common stock on the date of grant, and (ii) 1.8 shares for each share of common stock issued pursuant to any stock award that is not an appreciation award, also referred to as a “full value award.” The Amended 2015 Plan allows the Company to utilize a broad array of equity incentives and performance cash incentives in order to secure and retain the services of its employees, directors and consultants, and to provide long-term incentives that align the interests of its employees, directors and consultants with the interests of the Company’s stockholders. The Company accounts for stock-based compensation at estimated fair value. | text | 100 | percentItemType | text: <entity> 100 </entity> <entity type> percentItemType </entity type> <context> In May 2023, the Company’s stockholders approved the amendment and restatement of the Company’s 2015 Equity Incentive Plan (as so amended and restated, the “Amended 2015 Plan”). As of December 31, 2024, the remaining aggregate number of shares of the Company’s common stock available for future grants under the Amended 2015 Plan was 8,410,558 . The Amended 2015 Plan provides for the grant of stock-based awards, including nonqualified stock options, incentive stock options, restricted stock, restricted stock units (“RSUs”), stock appreciation rights and other equity securities to employees, consultants and non-employee directors of the Company and its affiliated entities. The number of shares of common stock available for issuance under the Amended 2015 Plan is reduced by (i) one share for each share of common stock issued pursuant to an appreciation award, such as a stock option or stock appreciation right with an exercise or strike price of at least 100 % of the fair market value of the underlying common stock on the date of grant, and (ii) 1.8 shares for each share of common stock issued pursuant to any stock award that is not an appreciation award, also referred to as a “full value award.” The Amended 2015 Plan allows the Company to utilize a broad array of equity incentives and performance cash incentives in order to secure and retain the services of its employees, directors and consultants, and to provide long-term incentives that align the interests of its employees, directors and consultants with the interests of the Company’s stockholders. The Company accounts for stock-based compensation at estimated fair value. </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent |
Beginning in March 2024, the RSUs granted to employees for service generally vest over three years, with 34% vesting on the first anniversary of the grant date and the remainder vesting ratably on a quarterly basis thereafter, subject to continued employment. RSUs granted prior to March 2024 generally vested over four years , with 25 % vesting on the first anniversary of the grant date and the remainder vesting ratably on a quarterly basis thereafter, subject to continued employment. Some RSUs granted to employees for performance vest upon the completion of defined performance goals, subject to continued employment. The RSUs granted to non-employee directors generally vest in full on the first anniversary of the grant date. The RSUs granted to non-employee consultants generally vest 50% on the first anniversary of the grant date, with the remaining 50% vesting quarterly thereafter through the second anniversary of the grant date. | text | 25 | percentItemType | text: <entity> 25 </entity> <entity type> percentItemType </entity type> <context> Beginning in March 2024, the RSUs granted to employees for service generally vest over three years, with 34% vesting on the first anniversary of the grant date and the remainder vesting ratably on a quarterly basis thereafter, subject to continued employment. RSUs granted prior to March 2024 generally vested over four years , with 25 % vesting on the first anniversary of the grant date and the remainder vesting ratably on a quarterly basis thereafter, subject to continued employment. Some RSUs granted to employees for performance vest upon the completion of defined performance goals, subject to continued employment. The RSUs granted to non-employee directors generally vest in full on the first anniversary of the grant date. The RSUs granted to non-employee consultants generally vest 50% on the first anniversary of the grant date, with the remaining 50% vesting quarterly thereafter through the second anniversary of the grant date. </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage |
As of December 31, 2024, the total unrecognized cost related to non-vested RSUs was approximately $ 46.8 million. This cost is expected to be recognized over a weighted-average period of 1.1 years. The Company recognized $ 63.5 million, $ 57.5 million and $ 43.2 million of stock-based compensation expense related to RSUs in the years ended December 31, 2024, 2023 and 2022, respectively. | text | 46.8 | monetaryItemType | text: <entity> 46.8 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the total unrecognized cost related to non-vested RSUs was approximately $ 46.8 million. This cost is expected to be recognized over a weighted-average period of 1.1 years. The Company recognized $ 63.5 million, $ 57.5 million and $ 43.2 million of stock-based compensation expense related to RSUs in the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized |
As of December 31, 2024, the total unrecognized cost related to non-vested RSUs was approximately $ 46.8 million. This cost is expected to be recognized over a weighted-average period of 1.1 years. The Company recognized $ 63.5 million, $ 57.5 million and $ 43.2 million of stock-based compensation expense related to RSUs in the years ended December 31, 2024, 2023 and 2022, respectively. | text | 63.5 | monetaryItemType | text: <entity> 63.5 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the total unrecognized cost related to non-vested RSUs was approximately $ 46.8 million. This cost is expected to be recognized over a weighted-average period of 1.1 years. The Company recognized $ 63.5 million, $ 57.5 million and $ 43.2 million of stock-based compensation expense related to RSUs in the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:RestrictedStockExpense |
As of December 31, 2024, the total unrecognized cost related to non-vested RSUs was approximately $ 46.8 million. This cost is expected to be recognized over a weighted-average period of 1.1 years. The Company recognized $ 63.5 million, $ 57.5 million and $ 43.2 million of stock-based compensation expense related to RSUs in the years ended December 31, 2024, 2023 and 2022, respectively. | text | 57.5 | monetaryItemType | text: <entity> 57.5 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the total unrecognized cost related to non-vested RSUs was approximately $ 46.8 million. This cost is expected to be recognized over a weighted-average period of 1.1 years. The Company recognized $ 63.5 million, $ 57.5 million and $ 43.2 million of stock-based compensation expense related to RSUs in the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:RestrictedStockExpense |
As of December 31, 2024, the total unrecognized cost related to non-vested RSUs was approximately $ 46.8 million. This cost is expected to be recognized over a weighted-average period of 1.1 years. The Company recognized $ 63.5 million, $ 57.5 million and $ 43.2 million of stock-based compensation expense related to RSUs in the years ended December 31, 2024, 2023 and 2022, respectively. | text | 43.2 | monetaryItemType | text: <entity> 43.2 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the total unrecognized cost related to non-vested RSUs was approximately $ 46.8 million. This cost is expected to be recognized over a weighted-average period of 1.1 years. The Company recognized $ 63.5 million, $ 57.5 million and $ 43.2 million of stock-based compensation expense related to RSUs in the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:RestrictedStockExpense |
The majority of the annual compensation the Company provides to non-employee members of its board of directors is paid in the form of RSUs. In addition, some members of the Company’s board of directors elect to receive their cash retainers, or a portion thereof, in the form of RSUs. An aggregate amount of approximately 60,000 , 55,000 and 57,000 service-based RSUs were granted to the Company’s non-employee directors as a result of these payments and elections during the years ended December 31, 2024, 2023 and 2022, respectively, with an estimated grant date fair value of $ 1.9 million, $ 2.9 million and $ 2.2 million, respectively. | text | 60000 | sharesItemType | text: <entity> 60000 </entity> <entity type> sharesItemType </entity type> <context> The majority of the annual compensation the Company provides to non-employee members of its board of directors is paid in the form of RSUs. In addition, some members of the Company’s board of directors elect to receive their cash retainers, or a portion thereof, in the form of RSUs. An aggregate amount of approximately 60,000 , 55,000 and 57,000 service-based RSUs were granted to the Company’s non-employee directors as a result of these payments and elections during the years ended December 31, 2024, 2023 and 2022, respectively, with an estimated grant date fair value of $ 1.9 million, $ 2.9 million and $ 2.2 million, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
The majority of the annual compensation the Company provides to non-employee members of its board of directors is paid in the form of RSUs. In addition, some members of the Company’s board of directors elect to receive their cash retainers, or a portion thereof, in the form of RSUs. An aggregate amount of approximately 60,000 , 55,000 and 57,000 service-based RSUs were granted to the Company’s non-employee directors as a result of these payments and elections during the years ended December 31, 2024, 2023 and 2022, respectively, with an estimated grant date fair value of $ 1.9 million, $ 2.9 million and $ 2.2 million, respectively. | text | 55000 | sharesItemType | text: <entity> 55000 </entity> <entity type> sharesItemType </entity type> <context> The majority of the annual compensation the Company provides to non-employee members of its board of directors is paid in the form of RSUs. In addition, some members of the Company’s board of directors elect to receive their cash retainers, or a portion thereof, in the form of RSUs. An aggregate amount of approximately 60,000 , 55,000 and 57,000 service-based RSUs were granted to the Company’s non-employee directors as a result of these payments and elections during the years ended December 31, 2024, 2023 and 2022, respectively, with an estimated grant date fair value of $ 1.9 million, $ 2.9 million and $ 2.2 million, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
The majority of the annual compensation the Company provides to non-employee members of its board of directors is paid in the form of RSUs. In addition, some members of the Company’s board of directors elect to receive their cash retainers, or a portion thereof, in the form of RSUs. An aggregate amount of approximately 60,000 , 55,000 and 57,000 service-based RSUs were granted to the Company’s non-employee directors as a result of these payments and elections during the years ended December 31, 2024, 2023 and 2022, respectively, with an estimated grant date fair value of $ 1.9 million, $ 2.9 million and $ 2.2 million, respectively. | text | 57000 | sharesItemType | text: <entity> 57000 </entity> <entity type> sharesItemType </entity type> <context> The majority of the annual compensation the Company provides to non-employee members of its board of directors is paid in the form of RSUs. In addition, some members of the Company’s board of directors elect to receive their cash retainers, or a portion thereof, in the form of RSUs. An aggregate amount of approximately 60,000 , 55,000 and 57,000 service-based RSUs were granted to the Company’s non-employee directors as a result of these payments and elections during the years ended December 31, 2024, 2023 and 2022, respectively, with an estimated grant date fair value of $ 1.9 million, $ 2.9 million and $ 2.2 million, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
The majority of the annual compensation the Company provides to non-employee members of its board of directors is paid in the form of RSUs. In addition, some members of the Company’s board of directors elect to receive their cash retainers, or a portion thereof, in the form of RSUs. An aggregate amount of approximately 60,000 , 55,000 and 57,000 service-based RSUs were granted to the Company’s non-employee directors as a result of these payments and elections during the years ended December 31, 2024, 2023 and 2022, respectively, with an estimated grant date fair value of $ 1.9 million, $ 2.9 million and $ 2.2 million, respectively. | text | 1.9 | monetaryItemType | text: <entity> 1.9 </entity> <entity type> monetaryItemType </entity type> <context> The majority of the annual compensation the Company provides to non-employee members of its board of directors is paid in the form of RSUs. In addition, some members of the Company’s board of directors elect to receive their cash retainers, or a portion thereof, in the form of RSUs. An aggregate amount of approximately 60,000 , 55,000 and 57,000 service-based RSUs were granted to the Company’s non-employee directors as a result of these payments and elections during the years ended December 31, 2024, 2023 and 2022, respectively, with an estimated grant date fair value of $ 1.9 million, $ 2.9 million and $ 2.2 million, respectively. </context> | us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross |
The majority of the annual compensation the Company provides to non-employee members of its board of directors is paid in the form of RSUs. In addition, some members of the Company’s board of directors elect to receive their cash retainers, or a portion thereof, in the form of RSUs. An aggregate amount of approximately 60,000 , 55,000 and 57,000 service-based RSUs were granted to the Company’s non-employee directors as a result of these payments and elections during the years ended December 31, 2024, 2023 and 2022, respectively, with an estimated grant date fair value of $ 1.9 million, $ 2.9 million and $ 2.2 million, respectively. | text | 2.9 | monetaryItemType | text: <entity> 2.9 </entity> <entity type> monetaryItemType </entity type> <context> The majority of the annual compensation the Company provides to non-employee members of its board of directors is paid in the form of RSUs. In addition, some members of the Company’s board of directors elect to receive their cash retainers, or a portion thereof, in the form of RSUs. An aggregate amount of approximately 60,000 , 55,000 and 57,000 service-based RSUs were granted to the Company’s non-employee directors as a result of these payments and elections during the years ended December 31, 2024, 2023 and 2022, respectively, with an estimated grant date fair value of $ 1.9 million, $ 2.9 million and $ 2.2 million, respectively. </context> | us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross |
The majority of the annual compensation the Company provides to non-employee members of its board of directors is paid in the form of RSUs. In addition, some members of the Company’s board of directors elect to receive their cash retainers, or a portion thereof, in the form of RSUs. An aggregate amount of approximately 60,000 , 55,000 and 57,000 service-based RSUs were granted to the Company’s non-employee directors as a result of these payments and elections during the years ended December 31, 2024, 2023 and 2022, respectively, with an estimated grant date fair value of $ 1.9 million, $ 2.9 million and $ 2.2 million, respectively. | text | 2.2 | monetaryItemType | text: <entity> 2.2 </entity> <entity type> monetaryItemType </entity type> <context> The majority of the annual compensation the Company provides to non-employee members of its board of directors is paid in the form of RSUs. In addition, some members of the Company’s board of directors elect to receive their cash retainers, or a portion thereof, in the form of RSUs. An aggregate amount of approximately 60,000 , 55,000 and 57,000 service-based RSUs were granted to the Company’s non-employee directors as a result of these payments and elections during the years ended December 31, 2024, 2023 and 2022, respectively, with an estimated grant date fair value of $ 1.9 million, $ 2.9 million and $ 2.2 million, respectively. </context> | us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross |
During the years ended December 31, 2024, 2023 and 2022, the Company granted approximately 1,691,000 , 746,000 and 1,082,000 service-based RSUs, respectively, to its employees, with an estimated aggregate grant date fair value of $ 49.9 million, $ 43.0 million and $ 44.2 million, respectively. | text | 1691000 | sharesItemType | text: <entity> 1691000 </entity> <entity type> sharesItemType </entity type> <context> During the years ended December 31, 2024, 2023 and 2022, the Company granted approximately 1,691,000 , 746,000 and 1,082,000 service-based RSUs, respectively, to its employees, with an estimated aggregate grant date fair value of $ 49.9 million, $ 43.0 million and $ 44.2 million, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
During the years ended December 31, 2024, 2023 and 2022, the Company granted approximately 1,691,000 , 746,000 and 1,082,000 service-based RSUs, respectively, to its employees, with an estimated aggregate grant date fair value of $ 49.9 million, $ 43.0 million and $ 44.2 million, respectively. | text | 746000 | sharesItemType | text: <entity> 746000 </entity> <entity type> sharesItemType </entity type> <context> During the years ended December 31, 2024, 2023 and 2022, the Company granted approximately 1,691,000 , 746,000 and 1,082,000 service-based RSUs, respectively, to its employees, with an estimated aggregate grant date fair value of $ 49.9 million, $ 43.0 million and $ 44.2 million, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
During the years ended December 31, 2024, 2023 and 2022, the Company granted approximately 1,691,000 , 746,000 and 1,082,000 service-based RSUs, respectively, to its employees, with an estimated aggregate grant date fair value of $ 49.9 million, $ 43.0 million and $ 44.2 million, respectively. | text | 1082000 | sharesItemType | text: <entity> 1082000 </entity> <entity type> sharesItemType </entity type> <context> During the years ended December 31, 2024, 2023 and 2022, the Company granted approximately 1,691,000 , 746,000 and 1,082,000 service-based RSUs, respectively, to its employees, with an estimated aggregate grant date fair value of $ 49.9 million, $ 43.0 million and $ 44.2 million, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
During the years ended December 31, 2024, 2023 and 2022, the Company granted approximately 1,691,000 , 746,000 and 1,082,000 service-based RSUs, respectively, to its employees, with an estimated aggregate grant date fair value of $ 49.9 million, $ 43.0 million and $ 44.2 million, respectively. | text | 49.9 | monetaryItemType | text: <entity> 49.9 </entity> <entity type> monetaryItemType </entity type> <context> During the years ended December 31, 2024, 2023 and 2022, the Company granted approximately 1,691,000 , 746,000 and 1,082,000 service-based RSUs, respectively, to its employees, with an estimated aggregate grant date fair value of $ 49.9 million, $ 43.0 million and $ 44.2 million, respectively. </context> | us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross |
During the years ended December 31, 2024, 2023 and 2022, the Company granted approximately 1,691,000 , 746,000 and 1,082,000 service-based RSUs, respectively, to its employees, with an estimated aggregate grant date fair value of $ 49.9 million, $ 43.0 million and $ 44.2 million, respectively. | text | 43.0 | monetaryItemType | text: <entity> 43.0 </entity> <entity type> monetaryItemType </entity type> <context> During the years ended December 31, 2024, 2023 and 2022, the Company granted approximately 1,691,000 , 746,000 and 1,082,000 service-based RSUs, respectively, to its employees, with an estimated aggregate grant date fair value of $ 49.9 million, $ 43.0 million and $ 44.2 million, respectively. </context> | us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross |
During the years ended December 31, 2024, 2023 and 2022, the Company granted approximately 1,691,000 , 746,000 and 1,082,000 service-based RSUs, respectively, to its employees, with an estimated aggregate grant date fair value of $ 49.9 million, $ 43.0 million and $ 44.2 million, respectively. | text | 44.2 | monetaryItemType | text: <entity> 44.2 </entity> <entity type> monetaryItemType </entity type> <context> During the years ended December 31, 2024, 2023 and 2022, the Company granted approximately 1,691,000 , 746,000 and 1,082,000 service-based RSUs, respectively, to its employees, with an estimated aggregate grant date fair value of $ 49.9 million, $ 43.0 million and $ 44.2 million, respectively. </context> | us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross |
During the years ended December 31, 2024, 2023 and 2022, the Company granted approximately 14,000 , 1,000 and 7,000 service-based RSUs, respectively, to non-employee consultants, with an estimated grant date fair value of $ 0.8 million, $ 0.1 million and $ 0.3 million, respectively. | text | 14000 | sharesItemType | text: <entity> 14000 </entity> <entity type> sharesItemType </entity type> <context> During the years ended December 31, 2024, 2023 and 2022, the Company granted approximately 14,000 , 1,000 and 7,000 service-based RSUs, respectively, to non-employee consultants, with an estimated grant date fair value of $ 0.8 million, $ 0.1 million and $ 0.3 million, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
During the years ended December 31, 2024, 2023 and 2022, the Company granted approximately 14,000 , 1,000 and 7,000 service-based RSUs, respectively, to non-employee consultants, with an estimated grant date fair value of $ 0.8 million, $ 0.1 million and $ 0.3 million, respectively. | text | 1000 | sharesItemType | text: <entity> 1000 </entity> <entity type> sharesItemType </entity type> <context> During the years ended December 31, 2024, 2023 and 2022, the Company granted approximately 14,000 , 1,000 and 7,000 service-based RSUs, respectively, to non-employee consultants, with an estimated grant date fair value of $ 0.8 million, $ 0.1 million and $ 0.3 million, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
During the years ended December 31, 2024, 2023 and 2022, the Company granted approximately 14,000 , 1,000 and 7,000 service-based RSUs, respectively, to non-employee consultants, with an estimated grant date fair value of $ 0.8 million, $ 0.1 million and $ 0.3 million, respectively. | text | 7000 | sharesItemType | text: <entity> 7000 </entity> <entity type> sharesItemType </entity type> <context> During the years ended December 31, 2024, 2023 and 2022, the Company granted approximately 14,000 , 1,000 and 7,000 service-based RSUs, respectively, to non-employee consultants, with an estimated grant date fair value of $ 0.8 million, $ 0.1 million and $ 0.3 million, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
During the years ended December 31, 2024, 2023 and 2022, the Company granted approximately 14,000 , 1,000 and 7,000 service-based RSUs, respectively, to non-employee consultants, with an estimated grant date fair value of $ 0.8 million, $ 0.1 million and $ 0.3 million, respectively. | text | 0.8 | monetaryItemType | text: <entity> 0.8 </entity> <entity type> monetaryItemType </entity type> <context> During the years ended December 31, 2024, 2023 and 2022, the Company granted approximately 14,000 , 1,000 and 7,000 service-based RSUs, respectively, to non-employee consultants, with an estimated grant date fair value of $ 0.8 million, $ 0.1 million and $ 0.3 million, respectively. </context> | us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross |
During the years ended December 31, 2024, 2023 and 2022, the Company granted approximately 14,000 , 1,000 and 7,000 service-based RSUs, respectively, to non-employee consultants, with an estimated grant date fair value of $ 0.8 million, $ 0.1 million and $ 0.3 million, respectively. | text | 0.1 | monetaryItemType | text: <entity> 0.1 </entity> <entity type> monetaryItemType </entity type> <context> During the years ended December 31, 2024, 2023 and 2022, the Company granted approximately 14,000 , 1,000 and 7,000 service-based RSUs, respectively, to non-employee consultants, with an estimated grant date fair value of $ 0.8 million, $ 0.1 million and $ 0.3 million, respectively. </context> | us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross |
During the years ended December 31, 2024, 2023 and 2022, the Company granted approximately 14,000 , 1,000 and 7,000 service-based RSUs, respectively, to non-employee consultants, with an estimated grant date fair value of $ 0.8 million, $ 0.1 million and $ 0.3 million, respectively. | text | 0.3 | monetaryItemType | text: <entity> 0.3 </entity> <entity type> monetaryItemType </entity type> <context> During the years ended December 31, 2024, 2023 and 2022, the Company granted approximately 14,000 , 1,000 and 7,000 service-based RSUs, respectively, to non-employee consultants, with an estimated grant date fair value of $ 0.8 million, $ 0.1 million and $ 0.3 million, respectively. </context> | us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross |
In March 2024, 2023 and 2022, the Company awarded approximately 461,000 , 193,000 and 248,000 performance-based RSUs, respectively, to the Company’s executives and employees (the “Bonus RSUs”), with an estimated grant date fair value of $ 13.7 million, $ 11.9 million and $ 9.7 million, respectively. Vesting of the Bonus RSUs is and was dependent upon the Company’s achievement of defined performance goals for the respective fiscal year in which the Bonus RSUs were granted. The Company records stock-based compensation expense related to performance-based RSUs when it is considered probable that the | text | 461000 | sharesItemType | text: <entity> 461000 </entity> <entity type> sharesItemType </entity type> <context> In March 2024, 2023 and 2022, the Company awarded approximately 461,000 , 193,000 and 248,000 performance-based RSUs, respectively, to the Company’s executives and employees (the “Bonus RSUs”), with an estimated grant date fair value of $ 13.7 million, $ 11.9 million and $ 9.7 million, respectively. Vesting of the Bonus RSUs is and was dependent upon the Company’s achievement of defined performance goals for the respective fiscal year in which the Bonus RSUs were granted. The Company records stock-based compensation expense related to performance-based RSUs when it is considered probable that the </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
In March 2024, 2023 and 2022, the Company awarded approximately 461,000 , 193,000 and 248,000 performance-based RSUs, respectively, to the Company’s executives and employees (the “Bonus RSUs”), with an estimated grant date fair value of $ 13.7 million, $ 11.9 million and $ 9.7 million, respectively. Vesting of the Bonus RSUs is and was dependent upon the Company’s achievement of defined performance goals for the respective fiscal year in which the Bonus RSUs were granted. The Company records stock-based compensation expense related to performance-based RSUs when it is considered probable that the | text | 193000 | sharesItemType | text: <entity> 193000 </entity> <entity type> sharesItemType </entity type> <context> In March 2024, 2023 and 2022, the Company awarded approximately 461,000 , 193,000 and 248,000 performance-based RSUs, respectively, to the Company’s executives and employees (the “Bonus RSUs”), with an estimated grant date fair value of $ 13.7 million, $ 11.9 million and $ 9.7 million, respectively. Vesting of the Bonus RSUs is and was dependent upon the Company’s achievement of defined performance goals for the respective fiscal year in which the Bonus RSUs were granted. The Company records stock-based compensation expense related to performance-based RSUs when it is considered probable that the </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
In March 2024, 2023 and 2022, the Company awarded approximately 461,000 , 193,000 and 248,000 performance-based RSUs, respectively, to the Company’s executives and employees (the “Bonus RSUs”), with an estimated grant date fair value of $ 13.7 million, $ 11.9 million and $ 9.7 million, respectively. Vesting of the Bonus RSUs is and was dependent upon the Company’s achievement of defined performance goals for the respective fiscal year in which the Bonus RSUs were granted. The Company records stock-based compensation expense related to performance-based RSUs when it is considered probable that the | text | 248000 | sharesItemType | text: <entity> 248000 </entity> <entity type> sharesItemType </entity type> <context> In March 2024, 2023 and 2022, the Company awarded approximately 461,000 , 193,000 and 248,000 performance-based RSUs, respectively, to the Company’s executives and employees (the “Bonus RSUs”), with an estimated grant date fair value of $ 13.7 million, $ 11.9 million and $ 9.7 million, respectively. Vesting of the Bonus RSUs is and was dependent upon the Company’s achievement of defined performance goals for the respective fiscal year in which the Bonus RSUs were granted. The Company records stock-based compensation expense related to performance-based RSUs when it is considered probable that the </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
In March 2024, 2023 and 2022, the Company awarded approximately 461,000 , 193,000 and 248,000 performance-based RSUs, respectively, to the Company’s executives and employees (the “Bonus RSUs”), with an estimated grant date fair value of $ 13.7 million, $ 11.9 million and $ 9.7 million, respectively. Vesting of the Bonus RSUs is and was dependent upon the Company’s achievement of defined performance goals for the respective fiscal year in which the Bonus RSUs were granted. The Company records stock-based compensation expense related to performance-based RSUs when it is considered probable that the | text | 13.7 | monetaryItemType | text: <entity> 13.7 </entity> <entity type> monetaryItemType </entity type> <context> In March 2024, 2023 and 2022, the Company awarded approximately 461,000 , 193,000 and 248,000 performance-based RSUs, respectively, to the Company’s executives and employees (the “Bonus RSUs”), with an estimated grant date fair value of $ 13.7 million, $ 11.9 million and $ 9.7 million, respectively. Vesting of the Bonus RSUs is and was dependent upon the Company’s achievement of defined performance goals for the respective fiscal year in which the Bonus RSUs were granted. The Company records stock-based compensation expense related to performance-based RSUs when it is considered probable that the </context> | us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross |
In March 2024, 2023 and 2022, the Company awarded approximately 461,000 , 193,000 and 248,000 performance-based RSUs, respectively, to the Company’s executives and employees (the “Bonus RSUs”), with an estimated grant date fair value of $ 13.7 million, $ 11.9 million and $ 9.7 million, respectively. Vesting of the Bonus RSUs is and was dependent upon the Company’s achievement of defined performance goals for the respective fiscal year in which the Bonus RSUs were granted. The Company records stock-based compensation expense related to performance-based RSUs when it is considered probable that the | text | 11.9 | monetaryItemType | text: <entity> 11.9 </entity> <entity type> monetaryItemType </entity type> <context> In March 2024, 2023 and 2022, the Company awarded approximately 461,000 , 193,000 and 248,000 performance-based RSUs, respectively, to the Company’s executives and employees (the “Bonus RSUs”), with an estimated grant date fair value of $ 13.7 million, $ 11.9 million and $ 9.7 million, respectively. Vesting of the Bonus RSUs is and was dependent upon the Company’s achievement of defined performance goals for the respective fiscal year in which the Bonus RSUs were granted. The Company records stock-based compensation expense related to performance-based RSUs when it is considered probable that the </context> | us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross |
In March 2024, 2023 and 2022, the Company awarded approximately 461,000 , 193,000 and 248,000 performance-based RSUs, respectively, to the Company’s executives and employees (the “Bonus RSUs”), with an estimated grant date fair value of $ 13.7 million, $ 11.9 million and $ 9.7 million, respectively. Vesting of the Bonus RSUs is and was dependent upon the Company’s achievement of defined performance goals for the respective fiscal year in which the Bonus RSUs were granted. The Company records stock-based compensation expense related to performance-based RSUs when it is considered probable that the | text | 9.7 | monetaryItemType | text: <entity> 9.7 </entity> <entity type> monetaryItemType </entity type> <context> In March 2024, 2023 and 2022, the Company awarded approximately 461,000 , 193,000 and 248,000 performance-based RSUs, respectively, to the Company’s executives and employees (the “Bonus RSUs”), with an estimated grant date fair value of $ 13.7 million, $ 11.9 million and $ 9.7 million, respectively. Vesting of the Bonus RSUs is and was dependent upon the Company’s achievement of defined performance goals for the respective fiscal year in which the Bonus RSUs were granted. The Company records stock-based compensation expense related to performance-based RSUs when it is considered probable that the </context> | us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross |
Additionally, during 2024, 2023 and 2022, the Company awarded approximately 303,000 , 134,000 and 167,000 performance-based RSUs, respectively, to the Company’s executives (the “Executive RSUs”). The estimated aggregate grant date fair value of the Executive RSUs for the 2024, 2023 and 2022 grants was $ 9.0 million, $ 8.2 million and $ 6.5 million, respectively. Vesting of the Executive RSUs is dependent upon the Company’s achievement of defined performance goals over a two-year period (the year of grant and the following year). The vesting of Executive RSUs will ultimately range from 0 % to 200 % of the number of shares underlying the Executive RSUs granted based on the level of achievement of the performance goals. | text | 303000 | sharesItemType | text: <entity> 303000 </entity> <entity type> sharesItemType </entity type> <context> Additionally, during 2024, 2023 and 2022, the Company awarded approximately 303,000 , 134,000 and 167,000 performance-based RSUs, respectively, to the Company’s executives (the “Executive RSUs”). The estimated aggregate grant date fair value of the Executive RSUs for the 2024, 2023 and 2022 grants was $ 9.0 million, $ 8.2 million and $ 6.5 million, respectively. Vesting of the Executive RSUs is dependent upon the Company’s achievement of defined performance goals over a two-year period (the year of grant and the following year). The vesting of Executive RSUs will ultimately range from 0 % to 200 % of the number of shares underlying the Executive RSUs granted based on the level of achievement of the performance goals. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
Additionally, during 2024, 2023 and 2022, the Company awarded approximately 303,000 , 134,000 and 167,000 performance-based RSUs, respectively, to the Company’s executives (the “Executive RSUs”). The estimated aggregate grant date fair value of the Executive RSUs for the 2024, 2023 and 2022 grants was $ 9.0 million, $ 8.2 million and $ 6.5 million, respectively. Vesting of the Executive RSUs is dependent upon the Company’s achievement of defined performance goals over a two-year period (the year of grant and the following year). The vesting of Executive RSUs will ultimately range from 0 % to 200 % of the number of shares underlying the Executive RSUs granted based on the level of achievement of the performance goals. | text | 134000 | sharesItemType | text: <entity> 134000 </entity> <entity type> sharesItemType </entity type> <context> Additionally, during 2024, 2023 and 2022, the Company awarded approximately 303,000 , 134,000 and 167,000 performance-based RSUs, respectively, to the Company’s executives (the “Executive RSUs”). The estimated aggregate grant date fair value of the Executive RSUs for the 2024, 2023 and 2022 grants was $ 9.0 million, $ 8.2 million and $ 6.5 million, respectively. Vesting of the Executive RSUs is dependent upon the Company’s achievement of defined performance goals over a two-year period (the year of grant and the following year). The vesting of Executive RSUs will ultimately range from 0 % to 200 % of the number of shares underlying the Executive RSUs granted based on the level of achievement of the performance goals. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
Additionally, during 2024, 2023 and 2022, the Company awarded approximately 303,000 , 134,000 and 167,000 performance-based RSUs, respectively, to the Company’s executives (the “Executive RSUs”). The estimated aggregate grant date fair value of the Executive RSUs for the 2024, 2023 and 2022 grants was $ 9.0 million, $ 8.2 million and $ 6.5 million, respectively. Vesting of the Executive RSUs is dependent upon the Company’s achievement of defined performance goals over a two-year period (the year of grant and the following year). The vesting of Executive RSUs will ultimately range from 0 % to 200 % of the number of shares underlying the Executive RSUs granted based on the level of achievement of the performance goals. | text | 167000 | sharesItemType | text: <entity> 167000 </entity> <entity type> sharesItemType </entity type> <context> Additionally, during 2024, 2023 and 2022, the Company awarded approximately 303,000 , 134,000 and 167,000 performance-based RSUs, respectively, to the Company’s executives (the “Executive RSUs”). The estimated aggregate grant date fair value of the Executive RSUs for the 2024, 2023 and 2022 grants was $ 9.0 million, $ 8.2 million and $ 6.5 million, respectively. Vesting of the Executive RSUs is dependent upon the Company’s achievement of defined performance goals over a two-year period (the year of grant and the following year). The vesting of Executive RSUs will ultimately range from 0 % to 200 % of the number of shares underlying the Executive RSUs granted based on the level of achievement of the performance goals. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
Additionally, during 2024, 2023 and 2022, the Company awarded approximately 303,000 , 134,000 and 167,000 performance-based RSUs, respectively, to the Company’s executives (the “Executive RSUs”). The estimated aggregate grant date fair value of the Executive RSUs for the 2024, 2023 and 2022 grants was $ 9.0 million, $ 8.2 million and $ 6.5 million, respectively. Vesting of the Executive RSUs is dependent upon the Company’s achievement of defined performance goals over a two-year period (the year of grant and the following year). The vesting of Executive RSUs will ultimately range from 0 % to 200 % of the number of shares underlying the Executive RSUs granted based on the level of achievement of the performance goals. | text | 9.0 | monetaryItemType | text: <entity> 9.0 </entity> <entity type> monetaryItemType </entity type> <context> Additionally, during 2024, 2023 and 2022, the Company awarded approximately 303,000 , 134,000 and 167,000 performance-based RSUs, respectively, to the Company’s executives (the “Executive RSUs”). The estimated aggregate grant date fair value of the Executive RSUs for the 2024, 2023 and 2022 grants was $ 9.0 million, $ 8.2 million and $ 6.5 million, respectively. Vesting of the Executive RSUs is dependent upon the Company’s achievement of defined performance goals over a two-year period (the year of grant and the following year). The vesting of Executive RSUs will ultimately range from 0 % to 200 % of the number of shares underlying the Executive RSUs granted based on the level of achievement of the performance goals. </context> | us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross |
Additionally, during 2024, 2023 and 2022, the Company awarded approximately 303,000 , 134,000 and 167,000 performance-based RSUs, respectively, to the Company’s executives (the “Executive RSUs”). The estimated aggregate grant date fair value of the Executive RSUs for the 2024, 2023 and 2022 grants was $ 9.0 million, $ 8.2 million and $ 6.5 million, respectively. Vesting of the Executive RSUs is dependent upon the Company’s achievement of defined performance goals over a two-year period (the year of grant and the following year). The vesting of Executive RSUs will ultimately range from 0 % to 200 % of the number of shares underlying the Executive RSUs granted based on the level of achievement of the performance goals. | text | 8.2 | monetaryItemType | text: <entity> 8.2 </entity> <entity type> monetaryItemType </entity type> <context> Additionally, during 2024, 2023 and 2022, the Company awarded approximately 303,000 , 134,000 and 167,000 performance-based RSUs, respectively, to the Company’s executives (the “Executive RSUs”). The estimated aggregate grant date fair value of the Executive RSUs for the 2024, 2023 and 2022 grants was $ 9.0 million, $ 8.2 million and $ 6.5 million, respectively. Vesting of the Executive RSUs is dependent upon the Company’s achievement of defined performance goals over a two-year period (the year of grant and the following year). The vesting of Executive RSUs will ultimately range from 0 % to 200 % of the number of shares underlying the Executive RSUs granted based on the level of achievement of the performance goals. </context> | us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross |
Additionally, during 2024, 2023 and 2022, the Company awarded approximately 303,000 , 134,000 and 167,000 performance-based RSUs, respectively, to the Company’s executives (the “Executive RSUs”). The estimated aggregate grant date fair value of the Executive RSUs for the 2024, 2023 and 2022 grants was $ 9.0 million, $ 8.2 million and $ 6.5 million, respectively. Vesting of the Executive RSUs is dependent upon the Company’s achievement of defined performance goals over a two-year period (the year of grant and the following year). The vesting of Executive RSUs will ultimately range from 0 % to 200 % of the number of shares underlying the Executive RSUs granted based on the level of achievement of the performance goals. | text | 6.5 | monetaryItemType | text: <entity> 6.5 </entity> <entity type> monetaryItemType </entity type> <context> Additionally, during 2024, 2023 and 2022, the Company awarded approximately 303,000 , 134,000 and 167,000 performance-based RSUs, respectively, to the Company’s executives (the “Executive RSUs”). The estimated aggregate grant date fair value of the Executive RSUs for the 2024, 2023 and 2022 grants was $ 9.0 million, $ 8.2 million and $ 6.5 million, respectively. Vesting of the Executive RSUs is dependent upon the Company’s achievement of defined performance goals over a two-year period (the year of grant and the following year). The vesting of Executive RSUs will ultimately range from 0 % to 200 % of the number of shares underlying the Executive RSUs granted based on the level of achievement of the performance goals. </context> | us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross |
Additionally, during 2024, 2023 and 2022, the Company awarded approximately 303,000 , 134,000 and 167,000 performance-based RSUs, respectively, to the Company’s executives (the “Executive RSUs”). The estimated aggregate grant date fair value of the Executive RSUs for the 2024, 2023 and 2022 grants was $ 9.0 million, $ 8.2 million and $ 6.5 million, respectively. Vesting of the Executive RSUs is dependent upon the Company’s achievement of defined performance goals over a two-year period (the year of grant and the following year). The vesting of Executive RSUs will ultimately range from 0 % to 200 % of the number of shares underlying the Executive RSUs granted based on the level of achievement of the performance goals. | text | 0 | percentItemType | text: <entity> 0 </entity> <entity type> percentItemType </entity type> <context> Additionally, during 2024, 2023 and 2022, the Company awarded approximately 303,000 , 134,000 and 167,000 performance-based RSUs, respectively, to the Company’s executives (the “Executive RSUs”). The estimated aggregate grant date fair value of the Executive RSUs for the 2024, 2023 and 2022 grants was $ 9.0 million, $ 8.2 million and $ 6.5 million, respectively. Vesting of the Executive RSUs is dependent upon the Company’s achievement of defined performance goals over a two-year period (the year of grant and the following year). The vesting of Executive RSUs will ultimately range from 0 % to 200 % of the number of shares underlying the Executive RSUs granted based on the level of achievement of the performance goals. </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage |
Additionally, during 2024, 2023 and 2022, the Company awarded approximately 303,000 , 134,000 and 167,000 performance-based RSUs, respectively, to the Company’s executives (the “Executive RSUs”). The estimated aggregate grant date fair value of the Executive RSUs for the 2024, 2023 and 2022 grants was $ 9.0 million, $ 8.2 million and $ 6.5 million, respectively. Vesting of the Executive RSUs is dependent upon the Company’s achievement of defined performance goals over a two-year period (the year of grant and the following year). The vesting of Executive RSUs will ultimately range from 0 % to 200 % of the number of shares underlying the Executive RSUs granted based on the level of achievement of the performance goals. | text | 200 | percentItemType | text: <entity> 200 </entity> <entity type> percentItemType </entity type> <context> Additionally, during 2024, 2023 and 2022, the Company awarded approximately 303,000 , 134,000 and 167,000 performance-based RSUs, respectively, to the Company’s executives (the “Executive RSUs”). The estimated aggregate grant date fair value of the Executive RSUs for the 2024, 2023 and 2022 grants was $ 9.0 million, $ 8.2 million and $ 6.5 million, respectively. Vesting of the Executive RSUs is dependent upon the Company’s achievement of defined performance goals over a two-year period (the year of grant and the following year). The vesting of Executive RSUs will ultimately range from 0 % to 200 % of the number of shares underlying the Executive RSUs granted based on the level of achievement of the performance goals. </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage |
If the Company achieves the performance goals for the Executive RSUs at the end of the two-year performance period, 50 % of the number of Executive RSUs earned based on performance will then vest on the second anniversary of the grant date, and the remaining 50 % will then vest on the third anniversary of the grant date, in each case subject to the executive’s continued service as of the vesting date. In March 2024 and 2023, the Company awarded approximately 83,000 and 55,000 additional shares related to performance-based RSUs granted to the Company’s executives for over-achievement of performance targets for the Executive RSUs with a performance period that ended December 31, 2023 and 2022, respectively. In March 2022, the Company cancelled approximately 50,000 shares related to performance-based RSUs granted to the Company’s executives for under-achievement of performance targets for the performance period that ended December 31, 2021. | text | 50 | percentItemType | text: <entity> 50 </entity> <entity type> percentItemType </entity type> <context> If the Company achieves the performance goals for the Executive RSUs at the end of the two-year performance period, 50 % of the number of Executive RSUs earned based on performance will then vest on the second anniversary of the grant date, and the remaining 50 % will then vest on the third anniversary of the grant date, in each case subject to the executive’s continued service as of the vesting date. In March 2024 and 2023, the Company awarded approximately 83,000 and 55,000 additional shares related to performance-based RSUs granted to the Company’s executives for over-achievement of performance targets for the Executive RSUs with a performance period that ended December 31, 2023 and 2022, respectively. In March 2022, the Company cancelled approximately 50,000 shares related to performance-based RSUs granted to the Company’s executives for under-achievement of performance targets for the performance period that ended December 31, 2021. </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage |
If the Company achieves the performance goals for the Executive RSUs at the end of the two-year performance period, 50 % of the number of Executive RSUs earned based on performance will then vest on the second anniversary of the grant date, and the remaining 50 % will then vest on the third anniversary of the grant date, in each case subject to the executive’s continued service as of the vesting date. In March 2024 and 2023, the Company awarded approximately 83,000 and 55,000 additional shares related to performance-based RSUs granted to the Company’s executives for over-achievement of performance targets for the Executive RSUs with a performance period that ended December 31, 2023 and 2022, respectively. In March 2022, the Company cancelled approximately 50,000 shares related to performance-based RSUs granted to the Company’s executives for under-achievement of performance targets for the performance period that ended December 31, 2021. | text | 83000 | sharesItemType | text: <entity> 83000 </entity> <entity type> sharesItemType </entity type> <context> If the Company achieves the performance goals for the Executive RSUs at the end of the two-year performance period, 50 % of the number of Executive RSUs earned based on performance will then vest on the second anniversary of the grant date, and the remaining 50 % will then vest on the third anniversary of the grant date, in each case subject to the executive’s continued service as of the vesting date. In March 2024 and 2023, the Company awarded approximately 83,000 and 55,000 additional shares related to performance-based RSUs granted to the Company’s executives for over-achievement of performance targets for the Executive RSUs with a performance period that ended December 31, 2023 and 2022, respectively. In March 2022, the Company cancelled approximately 50,000 shares related to performance-based RSUs granted to the Company’s executives for under-achievement of performance targets for the performance period that ended December 31, 2021. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease |
If the Company achieves the performance goals for the Executive RSUs at the end of the two-year performance period, 50 % of the number of Executive RSUs earned based on performance will then vest on the second anniversary of the grant date, and the remaining 50 % will then vest on the third anniversary of the grant date, in each case subject to the executive’s continued service as of the vesting date. In March 2024 and 2023, the Company awarded approximately 83,000 and 55,000 additional shares related to performance-based RSUs granted to the Company’s executives for over-achievement of performance targets for the Executive RSUs with a performance period that ended December 31, 2023 and 2022, respectively. In March 2022, the Company cancelled approximately 50,000 shares related to performance-based RSUs granted to the Company’s executives for under-achievement of performance targets for the performance period that ended December 31, 2021. | text | 55000 | sharesItemType | text: <entity> 55000 </entity> <entity type> sharesItemType </entity type> <context> If the Company achieves the performance goals for the Executive RSUs at the end of the two-year performance period, 50 % of the number of Executive RSUs earned based on performance will then vest on the second anniversary of the grant date, and the remaining 50 % will then vest on the third anniversary of the grant date, in each case subject to the executive’s continued service as of the vesting date. In March 2024 and 2023, the Company awarded approximately 83,000 and 55,000 additional shares related to performance-based RSUs granted to the Company’s executives for over-achievement of performance targets for the Executive RSUs with a performance period that ended December 31, 2023 and 2022, respectively. In March 2022, the Company cancelled approximately 50,000 shares related to performance-based RSUs granted to the Company’s executives for under-achievement of performance targets for the performance period that ended December 31, 2021. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease |
If the Company achieves the performance goals for the Executive RSUs at the end of the two-year performance period, 50 % of the number of Executive RSUs earned based on performance will then vest on the second anniversary of the grant date, and the remaining 50 % will then vest on the third anniversary of the grant date, in each case subject to the executive’s continued service as of the vesting date. In March 2024 and 2023, the Company awarded approximately 83,000 and 55,000 additional shares related to performance-based RSUs granted to the Company’s executives for over-achievement of performance targets for the Executive RSUs with a performance period that ended December 31, 2023 and 2022, respectively. In March 2022, the Company cancelled approximately 50,000 shares related to performance-based RSUs granted to the Company’s executives for under-achievement of performance targets for the performance period that ended December 31, 2021. | text | 50000 | sharesItemType | text: <entity> 50000 </entity> <entity type> sharesItemType </entity type> <context> If the Company achieves the performance goals for the Executive RSUs at the end of the two-year performance period, 50 % of the number of Executive RSUs earned based on performance will then vest on the second anniversary of the grant date, and the remaining 50 % will then vest on the third anniversary of the grant date, in each case subject to the executive’s continued service as of the vesting date. In March 2024 and 2023, the Company awarded approximately 83,000 and 55,000 additional shares related to performance-based RSUs granted to the Company’s executives for over-achievement of performance targets for the Executive RSUs with a performance period that ended December 31, 2023 and 2022, respectively. In March 2022, the Company cancelled approximately 50,000 shares related to performance-based RSUs granted to the Company’s executives for under-achievement of performance targets for the performance period that ended December 31, 2021. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.